Toshitaka Nabeshima

Toshitaka Nabeshima's AcademicInfluence.com Rankings

Toshitaka Nabeshima

Computer Science

#3694

World Rank

#3883

Historical Rank

Computational Linguistics

#236

World Rank

#240

Historical Rank

Machine Learning

#512

World Rank

#518

Historical Rank

Artificial Intelligence

#720

World Rank

#731

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Toshitaka Nabeshima's Degrees

PhD Computer Science University of Tokyo
Masters Computer Science University of Tokyo
Bachelors Computer Science University of Tokyo

Similar Degrees You Can Earn

Why Is Toshitaka Nabeshima Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Toshitaka Nabeshima's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Brain-derived neurotrophic factor/TrkB signaling in memory processes. (2003) (535)
Involvement of Brain-Derived Neurotrophic Factor in Spatial Memory Formation and Maintenance in a Radial Arm Maze Test in Rats (2000) (473)
Role for brain-derived neurotrophic factor in learning and memory. (2002) (367)
Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism. (1999) (316)
Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors (1998) (303)
Knockdown of DISC1 by In Utero Gene Transfer Disturbs Postnatal Dopaminergic Maturation in the Frontal Cortex and Leads to Adult Behavioral Deficits (2010) (298)
Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock (1990) (298)
Adolescent Stress–Induced Epigenetic Control of Dopaminergic Neurons via Glucocorticoids (2013) (281)
Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress (2003) (272)
β-Amyloid protein-induced Alzheimer's disease animal model (1994) (271)
Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphaninFQ receptor (1997) (256)
Phencyclidine animal models of schizophrenia: Approaches from abnormality of glutamatergic neurotransmission and neurodevelopment (2007) (253)
Protective effects of idebenone and α‐tocopherol on β‐amyloid‐(1–42)‐induced learning and memory deficits in rats: implication of oxidative stress in β‐amyloid‐induced neurotoxicity in vivo (1999) (234)
Social isolation rearing‐induced impairment of the hippocampal neurogenesis is associated with deficits in spatial memory and emotion‐related behaviors in juvenile mice (2008) (215)
CREB phosphorylation as a molecular marker of memory processing in the hippocampus for spatial learning (2002) (208)
Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine. (1989) (203)
Behavioral evidence for a modulating role of σ ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia (1994) (203)
A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by Aβ25–35 (2007) (200)
Neuroactive neurosteroids as endogenous effectors for the sigma1 (sigma1) receptor: pharmacological evidence and therapeutic opportunities. (1999) (195)
Behavioral abnormality and pharmacologic response in social isolation-reared mice (2009) (195)
Animal models of Alzheimer's disease and evaluation of anti-dementia drugs. (2000) (186)
Involvement of BDNF receptor TrkB in spatial memory formation. (2003) (183)
Dopamine D1 receptors regulate protein synthesis-dependent long-term recognition memory via extracellular signal-regulated kinase 1/2 in the prefrontal cortex. (2007) (178)
Silibinin prevents amyloid β peptide‐induced memory impairment and oxidative stress in mice (2009) (173)
Role of nitric oxide in learning and memory and in monoamine metabolism in the rat brain (1995) (167)
Simultaneous Measurement of Nitrite and Nitrate Levels as Indices of Nitric Oxide Release in the Cerebellum of Conscious Rats (1997) (167)
Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice. (1991) (166)
Neprilysin-sensitive Synapse-associated Amyloid-β Peptide Oligomers Impair Neuronal Plasticity and Cognitive Function* (2006) (165)
β-Amyloid (1–42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex (2004) (162)
Phosphatidylinositol 3-kinase: a molecule mediating BDNF-dependent spatial memory formation (2003) (161)
Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia (1995) (160)
Matrix Metalloproteinase-9 Contributes to Kindled Seizure Development in Pentylenetetrazole-Treated Mice by Converting Pro-BDNF to Mature BDNF in the Hippocampus (2011) (156)
Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes (2006) (156)
Oral vaccination with a viral vector containing Aβ cDNA attenuates age‐related Aβ accumulation and memory deficits without causing inflammation in a mouse Alzheimer model (2007) (154)
Continuous infusion of beta-amyloid protein into the rat cerebral ventricle induces learning impairment and neuronal and morphological degeneration. (1998) (154)
Role of Tumor Necrosis Factor-α in Methamphetamine-Induced Drug Dependence and Neurotoxicity (2004) (149)
Repeated Methamphetamine Treatment Impairs Recognition Memory Through a Failure of Novelty-Induced ERK1/2 Activation in the Prefrontal Cortex of Mice (2006) (149)
The effect of the loss of molar teeth on spatial memory and acetylcholine release from the parietal cortex in aged rats (1997) (148)
Combined effect of neonatal immune activation and mutant DISC1 on phenotypic changes in adulthood (2010) (142)
Mechanism of Action of Aripiprazole Predicts Clinical Efficacy and a Favourable Side-Effect Profile (2004) (139)
Disruption of the midkine gene (Mdk) resulted in altered expression of a calcium binding protein in the hippocampus of infant mice and their abnormal behaviour (1998) (138)
Stress-induced behavioral responses and multiple opioid systems in the brain (1995) (137)
A Role of Fos Expression in the CA3 Region of the Hippocampus in Spatial Memory Formation in Rats (2002) (137)
Chronic restraint stress impairs neurogenesis and hippocampus‐dependent fear memory in mice: possible involvement of a brain‐specific transcription factor Npas4 (2010) (136)
Neurobehavioral alterations in mice with a targeted deletion of the tumor necrosis factor-α gene: implications for emotional behavior (2000) (132)
Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors (2008) (131)
Mechanism of systemically injected interferon-alpha impeding monoamine biosynthesis in rats: role of nitric oxide as a signal crossing the blood–brain barrier (2003) (128)
The Allosteric Potentiation of Nicotinic Acetylcholine Receptors by Galantamine Ameliorates the Cognitive Dysfunction in Beta Amyloid25–35 I.c.v.-Injected Mice: Involvement of Dopaminergic Systems (2007) (128)
Impairments of long-term potentiation in hippocampal slices of beta-amyloid-infused rats. (1999) (127)
Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment (2001) (125)
Enhancement of spatial attention in nociceptin/orphanin FQ receptor-knockout mice (1998) (123)
Dysfunction of Cholinergic and Dopaminergic Neuronal Systems in β‐Amyloid Protein‐Infused Rats (1996) (122)
Neonatal polyI:C treatment in mice results in schizophrenia-like behavioral and neurochemical abnormalities in adulthood (2009) (120)
Nitric oxide synthase inhibitors impair reference memory formation in a radial arm maze task in rats (1998) (119)
The role of TNF-alpha and its receptors in the production of NGF and GDNF by astrocytes (2006) (119)
Step-down-type passive avoidance- and escape-learning method. Suitability for experimental amnesia models. (1986) (118)
Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy (2007) (118)
Hyperfunction of Dopaminergic and Serotonergic Neuronal Systems in Mice Lacking the NMDA Receptor ε1 Subunit (2001) (116)
PRE-084, a σ selective PCP derivative, attenuates MK-801-induced impairment of learning in mice (1994) (115)
Effect of a high linoleate and a high alpha-linolenate diet on general behavior and drug sensitivity in mice. (1993) (114)
The role of nitric oxide in dizocilpine-induced impairment of spontaneous alternation behavior in mice. (1996) (114)
The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release. (2004) (112)
N-Propargyl-1 (R)-aminoindan, rasagiline, increases glial cell line-derived neurotrophic factor (GDNF) in neuroblastoma SH-SY5Y cells through activation of NF-κB transcription factor (2004) (108)
Role of nitric oxide and cyclic GMP in the dizocilpine-induced impairment of spontaneous alternation behavior in mice (1996) (107)
Regulations of methamphetamine reward by extracellular signal-regulated kinase 1/2/ets-like gene-1 signaling pathway via the activation of dopamine receptors. (2004) (107)
Abnormalities of sensory and memory functions in mice lacking Bsg gene. (1997) (106)
Prostaglandin E receptor EP1 controls impulsive behavior under stress. (2005) (101)
Amyloid β‐peptide induces nitric oxide production in rat hippocampus: association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors (2001) (99)
Antiamnesic and Neuroprotective Effects of the Aminotetrahydrofuran Derivative ANAVEX1-41 Against Amyloid β25–35-Induced Toxicity in Mice (2009) (98)
Methamphetamine-induced neuronal protein NAT8L is the NAA biosynthetic enzyme: Implications for specialized acetyl coenzyme A metabolism in the CNS (2010) (97)
Memory impairment and neuronal dysfunction induced by beta-amyloid protein in rats. (1994) (96)
Ginsenoside Re Rescues Methamphetamine-Induced Oxidative Damage, Mitochondrial Dysfunction, Microglial Activation, and Dopaminergic Degeneration by Inhibiting the Protein Kinase Cδ Gene (2014) (96)
α7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in β-amyloid infused rats (2006) (95)
Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity. (2004) (94)
Repeated Phencyclidine Treatment Induces Negative Symptom-like Behavior in Forced Swimming Test in Mice: Imbalance of Prefrontal Serotonergic and Dopaminergic Functions (2000) (94)
Usefulness of soluble dietary fiber for the treatment of diarrhea during enteral nutrition in elderly patients. (2002) (94)
Improvement by nefiracetam of β‐amyloid‐(1‐42)‐induced learning and memory impairments in rats (1999) (92)
Behavioural and neurochemical features of olfactory bulbectomized rats resembling depression with comorbid anxiety (2007) (92)
Role of the mesotelencephalic dopamine system in learning and memory processes in the rat. (2003) (92)
Identification of Novel Candidate Genes for Treatment Response to Risperidone and Susceptibility for Schizophrenia: Integrated Analysis Among Pharmacogenomics, Mouse Expression, and Genetic Case-Control Association Approaches (2010) (90)
Loss of Antinociception Induced by Naloxone Benzoylhydrazone in Nociceptin Receptor-Knockout Mice* (1998) (90)
Involvement of a Dysfunctional Dopamine-D1/N-Methyl-d-aspartate-NR1 and Ca2+/Calmodulin-Dependent Protein Kinase II Pathway in the Impairment of Latent Learning in a Model of Schizophrenia Induced by Phencyclidine (2007) (89)
Restraining tumor necrosis factor-alpha by thalidomide prevents the Amyloid beta-induced impairment of recognition memory in mice (2008) (88)
Enhancement of hippocampal LTP, reference memory and sensorimotor gating in mutant mice lacking a telencephalon‐specific cell adhesion molecule (2001) (87)
Protective effects of idebenone and alpha-tocopherol on beta-amyloid-(1-42)-induced learning and memory deficits in rats: implication of oxidative stress in beta-amyloid-induced neurotoxicity in vivo. (1999) (87)
Memory deficits and increased emotionality induced by β-amyloid (25–35) are correlated with the reduced acetylcholine release and altered phorbol dibutyrate binding in the hippocampus (2001) (84)
Immunocytochemical evidence that amyloid β (1–42) impairs endogenous antioxidant systems in vivo (2003) (83)
Usp46 is a quantitative trait gene regulating mouse immobile behavior in the tail suspension and forced swimming tests (2009) (83)
Dissociation of impairment between spatial memory, and motor function and emotional behavior in aged rats (1998) (82)
Carbon monoxide-induced delayed amnesia, delayed neuronal death and change in acetylcholine concentration in mice. (1991) (81)
Lower Sensitivity to Stress and Altered Monoaminergic Neuronal Function in Mice Lacking the NMDA Receptor ε4 Subunit (2002) (81)
Brain serotonin depletion impairs short-term memory, but not long-term memory in rats (2007) (81)
A concussive-like brain injury model in mice (I): impairment in learning and memory. (1997) (80)
Brain dysfunction associated with an induction of nitric oxide synthase following an intracerebral injection of lipopolysaccharide in rats (1999) (80)
Effects of a Novel Cognitive Enhancer, Spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on Learning Impairments Induced by Amyloid-β1–40 in the Rat (2006) (79)
Tyrosine nitration of a synaptic protein synaptophysin contributes to amyloid β-peptide-induced cholinergic dysfunction (2003) (78)
Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor epsilon1 subunit. (2001) (78)
Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25–35) (2008) (78)
Involvement of Pallidotegmental Neurons in Methamphetamine- and MK-801-Induced Impairment of Prepulse Inhibition of the Acoustic Startle Reflex in Mice: Reversal by GABAB Receptor Agonist Baclofen (2008) (77)
Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment (2010) (76)
Reduction of methamphetamine‐induced sensitization and reward in matrix metalloproteinase‐2 and ‐9‐deficient mice (2006) (75)
Vulnerability in early life to changes in the rearing environment plays a crucial role in the aetiopathology of psychiatric disorders. (2011) (75)
Effects of N-methyl-D-aspartate receptor antagonists on carbon monoxide-induced brain damage in mice. (1992) (75)
Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine. (1987) (75)
Matrix Metalloprotease-9 Inhibition Improves Amyloid β-Mediated Cognitive Impairment and Neurotoxicity in Mice (2009) (74)
Animal Model of Schizophrenia (2006) (74)
Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer-type dementia (1995) (74)
Effects of memantine and donepezil on amyloid β-induced memory impairment in a delayed-matching to position task in rats (2005) (73)
Stress-induced changes in brain Met-enkephalin, Leu-enkephalin and dynorphin concentrations. (1992) (72)
Serotonergic involvement in phencyclidine-induced behaviors (1984) (71)
Effects of benzodiazepines on passive avoidance response and latent learning in mice: relationship to benzodiazepine receptors and the cholinergic neuronal system. (1990) (70)
Mutual regulation between the intercellular messengers nitric oxide and brain‐derived neurotrophic factor in rodent neocortical neurons (1999) (70)
MAGE-D1 Regulates Expression of Depression-Like Behavior through Serotonin Transporter Ubiquitylation (2012) (69)
A Novel Molecule “Shati” Is Involved in Methamphetamine-Induced Hyperlocomotion, Sensitization, and Conditioned Place Preference (2007) (69)
Modest Neuropsychological Deficits Caused by Reduced Noradrenaline Metabolism in Mice Heterozygous for a Mutated Tyrosine Hydroxylase Gene (2000) (69)
Role of matrix metalloproteinase and tissue inhibitor of MMP in methamphetamine‐induced behavioral sensitization and reward: implications for dopamine receptor down‐regulation and dopamine release (2007) (69)
Propentofylline improves learning and memory deficits in rats induced by beta-amyloid protein-(1-40). (1998) (68)
A concussive-like brain injury model in mice (II): selective neuronal loss in the cortex and hippocampus. (1997) (68)
Reduction in the number of NADPH-diaphorase-positive cells in the cerebral cortex and striatum in aged rats (1996) (68)
Hypofunctional glutamatergic neurotransmission in the prefrontal cortex is involved in the emotional deficit induced by repeated treatment with phencyclidine in mice: Implications for abnormalities of glutamate release and NMDA–CaMKII signaling (2007) (68)
Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats. (1998) (68)
Role of oxidative stress in methamphetamine-induced dopaminergic toxicity mediated by protein kinase Cδ (2012) (67)
Effects of haloperidol, sulpiride and SCH 23390 on passive avoidance learning in mice. (1988) (67)
Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol (2007) (67)
Opiate physical dependence and N-methyl-D-aspartate receptors. (2004) (66)
Apocynin prevents mitochondrial burdens, microglial activation, and pro-apoptosis induced by a toxic dose of methamphetamine in the striatum of mice via inhibition of p47phox activation by ERK (2016) (66)
Population pharmacokinetic analysis of vancomycin in patients with gram‐positive infections and the influence of infectious disease type (2009) (66)
The Rewards of Nicotine: Regulation by Tissue Plasminogen Activator–Plasmin System through Protease Activated Receptor-1 (2006) (66)
Current understanding of methamphetamine-associated dopaminergic neurodegeneration and psychotoxic behaviors (2017) (66)
Melatonin Attenuates Memory Impairment Induced by Klotho Gene Deficiency Via Interactive Signaling Between MT2 Receptor, ERK, and Nrf2-Related Antioxidant Potential (2015) (66)
Silibinin Attenuates Amyloid β25–35 Peptide-Induced Memory Impairments: Implication of Inducible Nitric-Oxide Synthase and Tumor Necrosis Factor-α in Mice (2009) (65)
Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin. (1994) (64)
Effect of lesions in the striatum, nucleus accumbens and medial raphe on phencyclidine-induced stereotyped behaviors and hyperactivity in rats. (1983) (64)
Matrix Metalloproteinases Contribute to Neuronal Dysfunction in Animal Models of Drug Dependence, Alzheimer's Disease, and Epilepsy (2011) (63)
Behavioral aspects of cholinergic transmission: role of basal forebrain cholinergic system in learning and memory. (1993) (63)
Two pathways of nitric oxide production through glutamate receptors in the rat cerebellum in vivo (1997) (63)
Effects of antidepressants on phencyclidine-induced enhancement of immobility in a forced swimming test in mice. (1997) (63)
Involvement of Nitric Oxide in Pentylenetetrazole‐Induced Kindling in Rats (2000) (62)
Pharmacokinetic Characteristics of 5‐Fluorouracil and Mitomycin C in Intraperitoneal Chemotherapy (1994) (62)
Effects of betaine on lipopolysaccharide-induced memory impairment in mice and the involvement of GABA transporter 2 (2011) (61)
Ultrastructure of internal limiting membrane removed during plasmin-assisted vitrectomy from eyes with diabetic macular edema. (2004) (61)
Role of Mitochondria in Methamphetamine-Induced Dopaminergic Neurotoxicity: Involvement in Oxidative Stress, Neuroinflammation, and Pro-apoptosis—A Review (2017) (60)
Sex-dependent differences in the pharmacological actions and pharmacokinetics of phencyclidine in rats. (1984) (60)
Inactivation of JAK2/STAT3 Signaling Axis and Downregulation of M1 mAChR Cause Cognitive Impairment in klotho Mutant Mice, a Genetic Model of Aging (2013) (60)
Neural Circuits Containing Pallidotegmental GABAergic Neurons are Involved in the Prepulse Inhibition of the Startle Reflex in Mice (2007) (60)
Beta-amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex. (2004) (59)
alpha7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in beta-amyloid infused rats. (2006) (59)
Role of nitric oxide in the effect of aging on spatial memory in rats (1997) (59)
Effects of DM-9384 in a model of amnesia based on animals with GABAergic neuronal dysfunctions. (1990) (58)
Neuronal mechanism of nociceptin-induced modulation of learning and memory: Involvement of N-methyl-D-aspartate receptors (2003) (58)
A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase (2004) (58)
Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis. (2007) (58)
Effects of vinconate on spatial learning impairments induced by medial septal lesion in rats. (1992) (57)
Enduring vulnerability to reinstatement of methamphetamine‐seeking behavior in glial cell line‐derived neurotrophic factor mutant mice (2007) (57)
Effects of σ 1 receptor agonist SA4503 and neuroactive steroids on performance in a radial arm maze task in rats (2000) (57)
Long‐term deprivation of oestrogens by ovariectomy potentiates β‐amyloid‐induced working memory deficits in rats (1999) (57)
Behavioural adaptations to addictive drugs in mice lacking the NMDA receptor ε1 subunit (2004) (57)
Effects of DM-9384, a cyclic derivative of GABA, on amnesia and decreases in GABAA and muscarinic receptors induced by cycloheximide. (1991) (57)
Protective potential of IL-6 against trimethyltin-induced neurotoxicity in vivo. (2012) (56)
Fustin flavonoid attenuates β‐amyloid (1–42)‐induced learning impairment (2009) (56)
Lower sensitivity to stress and altered monoaminergic neuronal function in mice lacking the NMDA receptor epsilon 4 subunit. (2002) (55)
The role of tissue plasminogen activator in methamphetamine‐related reward and sensitization (2005) (55)
Amlodipine, but not MDR1 polymorphisms, alters the pharmacokinetics of cyclosporine A in Japanese kidney transplant recipients1 (2003) (55)
Behavioral evidence for a modulating role of σ ligands in memory processes. II. Reversion of carbon monoxide-induced amnesia (1994) (55)
NGF level of is not decreased in the serum, brain-spinal fluid, hippocampus, or parietal cortex of individuals with Alzheimer's disease. (1993) (54)
Phencyclidine-induced head-weaving and head-twitch through interaction with 5-HT1 and 5-HT2 receptors in reserpinized rats (1987) (54)
Xanthoceraside attenuates amyloid β peptide25–35-induced learning and memory impairments in mice (2011) (54)
Effects of Dynorphin A (1-13) on Carbon Monoxide-Induced Delayed Amnesia in Mice (1997) (54)
Amyloid β-peptide induces cholinergic dysfunction and cognitive deficits: a minireview (2002) (54)
GABAergic Precursor Transplantation into the Prefrontal Cortex Prevents Phencyclidine-Induced Cognitive Deficits (2011) (54)
Involvement of Genetic and Environmental Factors in the Onset of Depression (2013) (53)
Interaction of BDNF/TrkB signaling with NMDA receptor in learning and memory. (2004) (53)
Acute and chronic effects of pentobarbital in relation to postsynaptic GABA receptors: A study with muscimol (1982) (53)
An Inducer for Glial Cell Line-Derived Neurotrophic Factor and Tumor Necrosis Factor–α Protects Against Methamphetamine-Induced Rewarding Effects and Sensitization (2007) (53)
Subcortical dopaminergic deficits in a DISC1 mutant model: a study in direct reference to human molecular brain imaging. (2013) (52)
Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor (2001) (52)
Denervation of dopaminergic neurons with 6-hydroxydopamine increases nerve growth factor content in rat brain (1992) (52)
Risks to health professionals from hazardous drugs in Japan: A pilot study of environmental and biological monitoring of occupational exposure to cyclophosphamide (2011) (52)
Phencyclidine Impairs Latent Learning in Mice: Interaction between Glutamatergic Systems and Sigma1 Receptors (2001) (51)
Possible Mechanism by Which the Carbapenem Antibiotic Panipenem Decreases the Concentration of Valproic Acid in Plasma in Rats (1998) (51)
Functional Analysis of Deep Intronic SNP rs13438494 in Intron 24 of PCLO Gene (2013) (51)
Effect of AD-5423 on animal models of schizophrenia: phencyclidine-induced behavioral changes in mice (2003) (51)
Liposomal melatonin rescues methamphetamine‐elicited mitochondrial burdens, pro‐apoptosis, and dopaminergic degeneration through the inhibition PKCδ gene (2015) (51)
Evaluation of emotional behaviors in young offspring of C57BL/6J mice after gestational and/or perinatal exposure to nicotine in six different time-windows (2013) (51)
Behavioral changes induced by stressful situations: effects of enkephalins, dynorphin, and their interactions. (1990) (51)
Galantamine ameliorates the impairment of recognition memory in mice repeatedly treated with methamphetamine: involvement of allosteric potentiation of nicotinic acetylcholine receptors and dopaminergic-ERK1/2 systems. (2010) (51)
The high atherosclerotic risk among epileptics: the atheroprotective role of multivitamins. (2005) (50)
Orally active NGF synthesis stimulators: potential therapeutic agents in alzheimer's disease (1997) (49)
Neurosteroids Ameliorate Conditioned Fear Stress: An Association with Sigma1 Receptors (2000) (49)
Effects of antipsychotics on the behavioral deficits in human dominant-negative DISC1 transgenic mice with neonatal polyI:C treatment (2011) (48)
Changes in NMDA receptor/ nitric oxide signaling pathway in the brain with aging (1998) (48)
Astroglial IFITM3 mediates neuronal impairments following neonatal immune challenge in mice (2013) (48)
Chronic unpredictable mild stress-induced behavioral changes are coupled with dopaminergic hyperfunction and serotonergic hypofunction in mouse models of depression (2019) (48)
Opposite effects induced by low and high doses of apomorphine on single-trial passive avoidance learning in mice (1988) (48)
Multicenter study for environmental and biological monitoring of occupational exposure to cyclophosphamide in Japan (2011) (48)
Motor and learning dysfunction during postnatal development in mice defective in dopamine neuronal transmission (1998) (48)
Spatial memory deficit and neurodegeneration induced by the direct injection of okadaic acid into the hippocampus in rats (2001) (47)
Involvement of nitric oxide in phencyclidine-induced hyperlocomotion in mice. (1995) (47)
UTILITY OF AN ELEVATED PLUS MAZE FOR THE EVALUATION OF NOOTROPICS, SCOPOLAMINE AND ELECTRO CONVULSIVE SHOCK (1990) (47)
Sustained brain‐derived neurotrophic factor up‐regulation and sensorimotor gating abnormality induced by postnatal exposure to phencyclidine: comparison with adult treatment (2006) (47)
Role of nociceptin systems in learning and memory (2000) (47)
Long-Lasting Impairment of Associative Learning Is Correlated with a Dysfunction of N-Methyl-d-aspartate-Extracellular Signaling-Regulated Kinase Signaling in Mice after Withdrawal from Repeated Administration of Phencyclidine (2005) (47)
Hippocampal Synaptic Modulation by the Phosphotyrosine Adapter Protein ShcC/N-Shc via Interaction with the NMDA Receptor (2005) (47)
Essential Role of NMDA Receptor Channel ε4 Subunit (GluN2D) in the Effects of Phencyclidine, but Not Methamphetamine (2010) (46)
Pre-Injury magnesium treatment prevents traumatic brain injury-induced hippocampal ERK activation, neuronal loss, and cognitive dysfunction in the radial-arm maze test. (2005) (46)
Memory impairment induced by chronic intracerebroventricular infusion of beta-amyloid (1–40) involves downregulation of protein kinase C (2002) (46)
An Analog of a Dipeptide-Like Structure of FK506 Increases Glial Cell Line-Derived Neurotrophic Factor Expression through cAMP Response Element-Binding Protein Activated by Heat Shock Protein 90/Akt Signaling Pathway (2006) (46)
Protective effect of interleukin-6 against the death of PC12 cells caused by serum deprivation or by the addition of a calcium ionophore. (1996) (46)
Evaluation of object-based attention in mice (2011) (46)
Dopaminergic agonists impair latent learning in mice: possible modulation by noradrenergic function. (1993) (46)
The attenuation of learning impairments induced after exposure to CO or trimethyltin in mice by sigma (σ) receptor ligands involves both σ1 and σ2 sites (1999) (45)
Nociceptin system plays a role in the memory retention: involvement of naloxone benzoylhydrazone binding sites. (1999) (45)
Interleukin-6 protects PC12 cells from 4-hydroxynonenal-induced cytotoxicity by increasing intracellular glutathione levels. (2002) (45)
Neuropsychotoxicity of abused drugs: involvement of matrix metalloproteinase-2 and -9 and tissue inhibitor of matrix metalloproteinase-2 in methamphetamine-induced behavioral sensitization and reward in rodents. (2008) (45)
Cholinergic modulation of memory for step-down type passive avoidance task in mice (1986) (45)
Protective effects of nicergoline against neuronal cell death induced by activated microglia and astrocytes (2005) (44)
Tumor Necrosis Factor-α and Its Inducer Inhibit Morphine-Induced Rewarding Effects and Sensitization (2007) (44)
Intracutaneous Distributions of Fluconazole, Itraconazole, and Griseofulvin in Guinea Pigs and Binding to Human Stratum Corneum (2004) (44)
Exposure to enriched environments during adolescence prevents abnormal behaviours associated with histone deacetylation in phencyclidine-treated mice. (2012) (43)
Dextromethorphan attenuates trimethyltin-induced neurotoxicity via σ1 receptor activation in rats (2007) (43)
Evaluation of cognitive behaviors in young offspring of C57BL/6J mice after gestational nicotine exposure during different time-windows (2013) (43)
The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) on stereotyped behavior in rats (1989) (42)
Differential effects of pimozide and SCH 23390 on acquisition of learning in mice. (1989) (42)
Synergistic effect of galantamine with risperidone on impairment of social interaction in phencyclidine-treated mice as a schizophrenic animal model (2007) (42)
Phencyclidine-induced stereotyped behaviors in rats following specific neurotoxin lesions of the striatum. (1983) (42)
Changes in muscarinic cholinergic, PCP, GABAA, D1, and 5-HT2A receptor binding, but not in benzodiazepine receptor binding in the brains of aged rats. (1994) (42)
Clozapine ameliorates epigenetic and behavioral abnormalities induced by phencyclidine through activation of dopamine D1 receptor. (2014) (42)
Effects of the novel compound NIK-247 on impairment of passive avoidance response in mice. (1988) (41)
Spatial memory deficits and oxidative stress damage following exposure to lipopolysaccharide in a rodent model of Parkinson's disease (2011) (41)
Effects of nicotine on memory impairment induced by blockade of muscarinic, nicotinic and dopamine D2 receptors in rats. (2003) (41)
Effects of metrifonate on memory impairment and cholinergic dysfunction in rats. (1997) (40)
NC-1900, an active fragment analog of arginine vasopressin, improves learning and memory deficits induced by beta-amyloid protein in rats. (1998) (40)
Drug dependence, synaptic plasticity, and tissue plasminogen activator. (2005) (40)
Juvenile social defeat stress exposure persistently impairs social behaviors and neurogenesis (2018) (40)
Mouse strain differences in phencyclidine-induced behavioural changes. (2012) (39)
The roles of glial cell line-derived neurotrophic factor, tumor necrosis factor-alpha, and an inducer of these factors in drug dependence. (2007) (39)
Sigma receptor ligands (+)-SKF10,047 and SA4503 improve dizocilpine-induced spatial memory deficits in rats. (1998) (39)
(+)-SKF-10,047 and dextromethorphan ameliorate conditioned fear stress through the activation of phenytoin-regulated sigma 1 sites. (1996) (39)
Identification of Piccolo as a regulator of behavioral plasticity and dopamine transporter internalization (2008) (39)
Prenatal NMDA Receptor Antagonism Impaired Proliferation of Neuronal Progenitor, Leading to Fewer Glutamatergic Neurons in the Prefrontal Cortex (2012) (39)
Inhibition of Neprilysin by Infusion of Thiorphan into the Hippocampus Causes an Accumulation of Amyloid β and Impairment of Learning and Memory (2006) (39)
Oral administration of idebenone, a stimulator of NGF synthesis, recovers reduced NGF content in aged rat brain (1993) (38)
Amyloid-β25–35 induces impairment of cognitive function and long-term potentiation through phosphorylation of collapsin response mediator protein 2 (2013) (38)
Involvement of dopaminergic system in phencyclidine-induced place preference in mice pretreated with phencyclidine repeatedly. (1998) (38)
ω-conotoxin GVIA protects against ischemia-induced neuronal death in the Mongolian gerbil but not against quinolinic acid-induced neurotoxicity in the rat (1994) (38)
Nicotine reverses scopolamine-induced impairment of performance in passive avoidance task in rats through its action on the dopaminergic neuronal system (1994) (38)
Effects of dopamine receptor agonists on passive avoidance learning in mice: interaction of dopamine D1 and D2 receptors. (1992) (38)
Antinociceptive activity induced by tizanidine and α 2-adrenoreceptors (1987) (37)
MK-801 increases endogenous acetylcholine release in the rat parietal cortex: a study using brain microdialysis (1993) (37)
Role of nitric oxide in the development of tolerance and sensitization to behavioural effects of phencyclidine in mice (1996) (37)
Effects of repeated administration of propentofylline on memory impairment produced by basal forebrain lesion in rats. (1993) (37)
Protective Potential of the Glutathione Peroxidase-1 Gene in Abnormal Behaviors Induced by Phencyclidine in Mice (2017) (37)
Excess maternal fructose consumption impairs hippocampal function in offspring via epigenetic modification of BDNF promoter (2018) (37)
Mouse model of relapse to the abuse of drugs: Procedural considerations and characterizations (2009) (37)
PKCδ inhibition enhances tyrosine hydroxylase phosphorylation in mice after methamphetamine treatment (2011) (37)
Astroglial major histocompatibility complex class I following immune activation leads to behavioral and neuropathological changes (2018) (37)
Spatiotemporal expression of BDNF in the hippocampus induced by the continuous intracerebroventricular infusion of beta-amyloid in rats. (2000) (36)
Interference of Hematocrit in the Tacrolimus II Microparticle Enzyme Immunoassay (2002) (36)
Morphine tolerance and dependence in the nociceptin receptor knockout mice (2001) (36)
Discontinuation of donepezil for the treatment of Alzheimer's disease in geriatric practice (2008) (36)
Pro‐ and Anti‐Addictive Neurotrophic Factors and Cytokines in Psychostimulant Addiction: Mini Review (2004) (36)
N-Methyl, N-propynyl-2-phenylethylamine (MPPE), a Selegiline Analog, Attenuates MPTP-induced Dopaminergic Toxicity with Guaranteed Behavioral Safety: Involvement of Inhibitions of Mitochondrial Oxidative Burdens and p53 Gene-elicited Pro-apoptotic Change (2016) (36)
Prenatal Nicotine Exposure Impairs the Proliferation of Neuronal Progenitors, Leading to Fewer Glutamatergic Neurons in the Medial Prefrontal Cortex (2016) (36)
Methysergide-induced precipitated withdrawal syndrome in phencyclidine-dependent rats (1986) (35)
Staurosporine facilitates recovery from the basal forebrain-lesion-induced impairment of learning and deficit of cholinergic neuron in rats. (1991) (35)
Serum Metabolic Profiles of the Tryptophan-Kynurenine Pathway in the high risk subjects of major depressive disorder (2020) (35)
Blonanserin Ameliorates Phencyclidine-Induced Visual-Recognition Memory Deficits: the Complex Mechanism of Blonanserin Action Involving D3-5-HT2A and D1-NMDA Receptors in the mPFC (2015) (35)
A role played by dopamine and opioid neuronal systems in stress-induced motor suppression (conditioned suppression of motility) in mice. (1986) (35)
Involvement of Matrix Metalloproteinase-Mediated Proteolysis of Neural Cell Adhesion Molecule in the Development of Cerebral Ischemic Neuronal Damage (2011) (35)
A selective phosphodiesterase IV inhibitor, rolipram blocks both withdrawal behavioral manifestations, and c-Fos protein expression in morphine dependent mice (2001) (35)
Regulation of nerve growth factor release by nitric oxide through cyclic GMP pathway in cortical glial cells. (1999) (35)
Oral administration of NGF synthesis stimulators recovers reduced brain NGF content in aged rats and cognitive dysfunction in basal-forebrain-lesioned rats. (1994) (35)
PRE-084, a sigma selective PCP derivative, attenuates MK-801-induced impairment of learning in mice. (1994) (35)
Synthesis and Preliminary Evaluation of [11C]NE-100 Labeled in Two Different Positions as a PET σ Receptor Ligand (1998) (34)
Behavioural adaptations to addictive drugs in mice lacking the NMDA receptor epsilon1 subunit. (2004) (34)
Depressive symptoms as a side effect of Interferon-α therapy induced by induction of indoleamine 2,3-dioxygenase 1 (2016) (34)
Prenatal nicotine exposure decreases the release of dopamine in the medial frontal cortex and induces atomoxetine-responsive neurobehavioral deficits in mice (2017) (34)
Relapse of methamphetamine-seeking behavior in C57BL/6J mice demonstrated by a reinstatement procedure involving intravenous self-administration (2006) (34)
Effect of Dietary Fiber on Morphine-induced Constipation in Rats (2002) (34)
Inhibition of enkephalin degradation attenuated stress-induced motor suppression (conditioned suppression of motility). (1988) (34)
Inhibition of neprilysin by thiorphan (i.c.v.) causes an accumulation of amyloid β and impairment of learning and memory (2006) (34)
Inhibitory effect of erythromycin on P-glycoprotein-mediated biliary excretion of doxorubicin in rats. (2000) (34)
Extracellular and intraneuronal HMW-AbetaOs represent a molecular basis of memory loss in Alzheimer's disease model mouse (2011) (34)
Enhanced antidepressant efficacy of σ1 receptor agonists in rats after chronic intracerebroventricular infusion of β-amyloid-(1–40) protein (2004) (34)
Effects of chronic administration of pentobarbital or morphine on the brain microsomal cytochrome P-450 system. (1981) (34)
Pharmacological responses to pentobarbital in different strains of mice. (1981) (34)
The long-lasting effects of cross-fostering on the emotional behavior in ICR mice (2009) (33)
Transient drug-primed but persistent cue-induced reinstatement of extinguished methamphetamine-seeking behavior in mice (2007) (33)
Absence of SHATI/Nat8l reduces social interaction in mice (2012) (33)
Ubiquitin-Specific Peptidase 46 (Usp46) Regulates Mouse Immobile Behavior in the Tail Suspension Test through the GABAergic System (2012) (33)
Involvement of matrix metalloproteinase-9 in the development of morphine tolerance. (2012) (33)
Learning and memory in two different reward tasks in a radial arm maze in rats (2002) (32)
An Analysis of GABA Receptor Changes in the Discrete Regions of Mouse Brain After Acute and Chronic Treatments with Morphine (1982) (32)
IL-6 attenuates trimethyltin-induced cognitive dysfunction via activation of JAK2/STAT3, M1 mAChR and ERK signaling network. (2013) (32)
PKC&dgr;‐dependent p47phox activation mediates methamphetamine‐induced dopaminergic neurotoxicity (2018) (32)
Possible involvement of nitric oxide in quinolinic acid-induced convulsion in mice (1995) (32)
Effects of successive carbon monoxide exposures on delayed neuronal death in mice under the maintenance of normal body temperature. (1991) (32)
Neurotoxicity induced by continuous infusion of quinolinic acid into the lateral ventricle in rats (1990) (31)
Possible Involvement of Catalase in the Protective Effect of Interleukin-6 Against 6-Hydroxydopamine Toxicity in PC12 Cells (1997) (31)
Subcutaneous tissue distribution of vancomycin from a fibrin glue/Dacron graft carrier. (1997) (31)
Genetic and animal model analyses reveal the pathogenic role of a novel deletion of RELN in schizophrenia (2018) (31)
Effects of 5-HT2 receptor antagonist on cycloheximide-induced amnesia in mice (1989) (31)
Effects of DM-9384, a pyrrolidone derivative, on alcohol- and chlordiazepoxide-induced amnesia in mice (1990) (30)
Oral mucosal adhesive film containing local anesthetics: in vitro and clinical evaluation. (1998) (30)
Degradation of PEP-19, a calmodulin-binding protein, by calpain is implicated in neuronal cell death induced by intracellular Ca2+ overload (2008) (30)
Role of nociceptin/orphanin FQ (Noc/oFQ) in murine experimental colitis (2005) (30)
Neuropsychotoxic and neuroprotective potentials of dextromethorphan and its analogs. (2011) (30)
Exposure to extremely low frequency magnetic fields enhances locomotor activity via activation of dopamine D1-like receptors in mice. (2007) (30)
Piccolo knockdown-induced impairments of spatial learning and long-term potentiation in the hippocampal CA1 region (2010) (30)
Comparison of alpha-adrenoceptor involvement in the antinociceptive action of tizanidine and clonidine in the mouse. (1986) (30)
Acute phencyclidine induces aversion, but repeated phencyclidine induces preference in the place conditioning test in rats. (1996) (30)
The role of nociceptin in cognition (1999) (29)
Molecular mechanisms for nicotine intoxication (2019) (29)
Alterations in pharmacokinetics and protein binding behavior of cefazolin in endotoxemic rats (1993) (29)
Characteristics of transient cerebral ischemia-induced deficits on various learning and memory tasks in male Mongolian gerbils. (1993) (29)
Role of sex hormones in sex-dependent differences in phencyclidine-induced stereotyped behaviors in rats. (1984) (29)
Evaluation of a novel sugar coating method for moisture protective tablets. (2007) (29)
Effect of anti-epileptic drugs on serum zinc and copper concentrations in epileptic patients. (1993) (29)
Role of tumor necrosis factor-alpha in down-regulation of hepatic cytochrome P450 and P-glycoprotein by endotoxin. (2005) (29)
Effects of nefiracetam on drug-induced impairment of latent learning in mice in a water finding task. (1994) (29)
Suppression of neurocognitive damage in LP‐BM5‐infected mice with a targeted deletion of the TNF‐α gene (2000) (29)
Changes In Absorptive Function Of Rat Intestine Injured By Methotrexate (2000) (28)
Acute and chronic phencyclidine administration changes serotonin receptors in rat brain. (1985) (28)
Activation of both dopamine D1 and D2 receptors necessary for amelioration of conditioned fear stress. (1995) (28)
Protein Kinase Cδ Gene Depletion Protects Against Methamphetamine-Induced Impairments in Recognition Memory and ERK1/2 Signaling via Upregulation of Glutathione Peroxidase-1 Gene (2017) (28)
Pharmacist-managed clinics for patient education and counseling in Japan: current status and future perspectives (2015) (28)
Molecular mechanisms in dizocilpine-induced attenuation of development of morphine dependence: an association with cortical Ca2+/calmodulin-dependent signal cascade (2004) (28)
Overexpression of Shati/Nat8l, an N-acetyltransferase, in the nucleus accumbens attenuates the response to methamphetamine via activation of group II mGluRs in mice. (2014) (28)
Synergistic effect of combined treatment with risperidone and galantamine on phencyclidine-induced impairment of latent visuospatial learning and memory: Role of nAChR activation-dependent increase of dopamine D1 receptor-mediated neurotransmission (2007) (28)
Involvement of the cholinergic system in the effects of nefiracetam (DM-9384) on carbon monoxide (CO)-induced acute and delayed amnesia. (1992) (28)
Memory impairment and neural dysfunction after continuous infusion of anti-nerve growth factor antibody into the septum in adult rats (1993) (27)
Pharmacokinetics of doxorubicin and its active metabolite in patients with normal renal function and in patients on hemodialysis (2004) (27)
Role of cholinergic and GABAergic neuronal systems in cycloheximide-induced amnesia in mice (1988) (27)
The necessity of adjusting the dosage of zonisamide when coadministered with other anti-epileptic drugs. (1996) (27)
Role of (+)-SKF-10,047-sensitive sub-population of sigma 1 receptors in amelioration of conditioned fear stress in rats: association with mesolimbic dopaminergic systems. (1997) (27)
Effects of Picrotoxin Treatment on GABAA Receptor Supramolecular Complexes in Rat Brain (1989) (26)
Amyloid pathology and protein kinase C (PKC): possible therapeutics effects of PKC activators. (2005) (26)
Nefiracetam elevates extracellular acetylcholine level in the frontal cortex of rats with cerebral cholinergic dysfunctions: an in vivo microdialysis study (1998) (26)
Role of convergent activation of glutamatergic and dopaminergic systems in the nucleus accumbens in the development of methamphetamine psychosis and dependence. (2013) (26)
Possible involvement of protease‐activated receptor‐1 in the regulation of morphine‐induced dopamine release and hyperlocomotion by the tissue plasminogen activator‐plasmin system (2007) (26)
Modification by the tissue plasminogen activator–plasmin system of morphine‐induced dopamine release and hyperlocomotion, but not anti‐nociceptive effect in mice (2005) (26)
MK-801 ameliorates delayed amnesia, but potentiates acute amnesia induced by CO (1990) (26)
Parishin C attenuates phencyclidine-induced schizophrenia-like psychosis in mice: involvements of 5-HT1A receptor. (2010) (26)
Phencyclidine-induced head-twitch responses as 5-HT2 receptor-mediated behavior in rats (1987) (26)
Comparative study of acute effects of single doses of fexofenadine, olopatadine, d‐chlorpheniramine and placebo on psychomotor function in healthy volunteers (2003) (26)
Interspecies Differences and Scaling for the Pharmacokinetics of Xanthine Derivatives (1992) (25)
Time‐dependent Effects of Klebsiella pneumoniae Endotoxin on Hepatic Drug‐metabolizing Enzyme Activity in Rats (1998) (25)
Effects of 5-hydroxytryptamine on defecation in open-field behavior in rats (1980) (25)
Attenuation of the development of morphine dependence/tolerance by nefiracetam: involvement of adenosine 3′:5′-cyclic monophosphate system (2000) (25)
Phencyclidine-induced head-twitch response in rats treated chronically with methysergide. (1987) (25)
Involvement of Activation of Dopamineraic Neuronal System in Learning and Memory Deficits Associated with Experimental Mild Traumatic Brain Injury (1997) (25)
Prescription profiles for pharmacological treatment of Japanese inpatients with schizophrenia: comparison between 2007 and 2009 (2012) (25)
Platelet-activating factor receptor knockout mice are protected from MPTP-induced dopaminergic degeneration (2013) (24)
Lipopolysaccharide shock reveals the immune function of indoleamine 2,3-dioxygenase 2 through the regulation of IL-6/stat3 signalling (2018) (24)
Aged-related changes in learning and memory, choline acetyltransferase activity and number of neuronal cells in rats. (1991) (24)
Phencyclidine-induced discriminative stimulus is mediated via phencyclidine binding sites on the N-methyl-d-aspartate receptor-ion channel complex, not via sigma1 receptors (2001) (24)
Reelin has a preventive effect on phencyclidine-induced cognitive and sensory-motor gating deficits (2015) (24)
The Extensive Nitration of Neurofilament Light Chain in the Hippocampus Is Associated with the Cognitive Impairment Induced by Amyloid β in Mice (2008) (24)
Impairment of learning and memory and the accessory symptom in aged rat as senile dementia model (3): Oral administration of propentofylline produces recovery of reduced NGF content in the brain of aged rats. (1993) (24)
Effects of oral administration of chlordecone and mirex on brain biogenic amines in mice. (1982) (24)
Reversal of alcohol-induced amnesia by the benzodiazepine inverse agonist Ro 15-4513. (1988) (24)
An Environmental and Biological Study of Occupational Exposure to Cyclophosphamide in the Pharmacy of a Japanese Community Hospital Designated for the Treatment of Cancer (2009) (23)
Role of N-Methyl-D-aspartate Receptors in Antidepressant-Like Effects of σ1 Receptor Agonist 1-(3,4-Dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine Dihydrochloride (SA-4503) in Olfactory Bulbectomized Rats (2007) (23)
The antidepressant-like effects of the 3β-hydroxysteroid dehydrogenase inhibitor trilostane in mice is related to changes in neuroactive steroid and monoamine levels (2012) (23)
Genetic or pharmacological depletion of cannabinoid CB1 receptor protects against dopaminergic neurotoxicity induced by methamphetamine in mice (2017) (23)
YY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by β-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2 (2017) (23)
Role of dopaminergic and GABAergic mechanisms in discrete brain areas in phencyclidine-induced locomotor stimulation and turning behavior. (1986) (23)
Age‐related expression of σ1 receptors and antidepressant efficacy of a selective agonist in the senescence‐accelerated (SAM) mouse (2005) (23)
Discriminative-stimulus effects of methamphetamine and morphine in rats are attenuated by cAMP-related compounds (2006) (23)
Ginsenosides attenuate methamphetamine-induced behavioral side effects in mice via activation of adenosine A2A receptors: possible involvements of the striatal reduction in AP-1 DNA binding activity and proenkephalin gene expression (2005) (23)
Involvement of glial cell line-derived neurotrophic factor in inhibitory effects of a hydrophobic dipeptide Leu-Ile on morphine-induced sensitization and rewarding effects (2007) (23)
GABAergic modulation of memory with regard to passive avoidance and conditioned suppression tasks in mice (2004) (22)
Changes in tryptophan metabolism during pregnancy and postpartum periods: Potential involvement in postpartum depressive symptoms. (2019) (22)
Involvement of hippocampal extracellular signal-regulated kinase 1/2 in spatial working memory in rats (2006) (22)
Seasonal changes in NRF2 antioxidant pathway regulates winter depression-like behavior (2020) (22)
ARHGAP10, which encodes Rho GTPase-activating protein 10, is a novel gene for schizophrenia risk (2020) (22)
Genetic animal models of schizophrenia related with the hypothesis of abnormal neurodevelopment. (2011) (22)
Neuropharmacological characterization of voltage-sensitive calcium channels: possible existence of neomycin-sensitive, omega-conotoxin GVIA- and dihydropyridines-resistant calcium channels in the rat brain. (1993) (22)
Exposure to far-infrared rays attenuates methamphetamine-induced recognition memory impairment via modulation of the muscarinic M1 receptor, Nrf2, and PKC (2018) (22)
The modulator role of the hypothalamic paraventricular nucleus on immune responsiveness (2004) (22)
Changes in ciliary neurotrophic factor content in the rat brain after continuous intracerebroventricular infusion of β-amyloid(1–40) protein (1995) (22)
Prenatal exposure to PCP produces behavioral deficits accompanied by the overexpression of GLAST in the prefrontal cortex of postpubertal mice (2011) (22)
NGFI-B, c-fos, and c-jun mRNA Expression in Mouse Brain after Acute Carbon Monoxide Intoxication (1997) (22)
Effect of a bacterial lipopolysaccharide on biliary excretion of a beta-lactam antibiotic, cefoperazone, in rats (1995) (22)
Contribution of different opioid systems to footshock-induced analgesia and motor suppression. (1983) (22)
Development of dispositional tolerance to phencyclidine by osmotic minipump in the mouse. (1982) (22)
The hydrophobic dipeptide Leu–Ile inhibits immobility induced by repeated forced swimming via the induction of BDNF (2011) (22)
Prenatal phencyclidine treatment induces behavioral deficits through impairment of GABAergic interneurons in the prefrontal cortex (2016) (22)
Cerebellar α6‐subunit‐containing GABAA receptors: a novel therapeutic target for disrupted prepulse inhibition in neuropsychiatric disorders (2018) (22)
Involvement of Tissue Plasminogen Activator-Plasmin System in Depolarization-Evoked Dopamine Release in the Nucleus Accumbens of Mice (2006) (22)
Cholecystokinin-related peptides, after systemic or central administration, prevent carbon monoxide-induced amnesia in mice. (1994) (22)
Effects of propentofylline, a NGF synthesis stimulator, on alterations in muscarinic cholinergic receptors induced by basal forebrain lesion in rats (1993) (21)
Ginsenoside Re protects against phencyclidine-induced behavioral changes and mitochondrial dysfunction via interactive modulation of glutathione peroxidase-1 and NADPH oxidase in the dorsolateral cortex of mice. (2017) (21)
Memory impairment and morphological changes in rats induced by active fragment of anti-nerve growth factor-antibody. (1991) (21)
The role of Cyclophilin D in learning and memory (2009) (21)
(+)-SKF-10,047 and dextromethorphan ameliorate conditioned fear stress via dopaminergic systems linked to phenytoin-regulated sigma 1 sites. (1996) (21)
Tissue-type plasminogen activator deficiency attenuates peritoneal fibrosis in mice. (2009) (21)
Effects of nefiracetam on amnesia animal models with neuronal dysfunctions (1997) (21)
Repeated exposure to far infrared ray attenuates acute restraint stress in mice via inhibition of JAK2/STAT3 signaling pathway by induction of glutathione peroxidase-1 (2016) (21)
Effects of phencyclidine on behavior and extracellular levels of dopamine and its metabolites in neonatal ventral hippocampal damaged rats (2000) (21)
Effects of lifelong intake of lemon polyphenols on aging and intestinal microbiome in the senescence-accelerated mouse prone 1 (SAMP1) (2019) (21)
Perspectives of pharmacotherapy in Alzheimer's disease. (1999) (21)
Risperidone prevents the development of supersensitivity, but not tolerance, to phencyclidine in rats treated with subacute phencyclidine. (1995) (21)
Characterization of learning and memory deficits in C57BL/6 mice infected with LP-BM5, a murine model of AIDS (1999) (21)
Overexpression of piccolo C2A domain induces depression-like behavior in mice (2010) (21)
A therapeutic strategy to prevent morphine dependence and tolerance by coadministration of cAMP-related reagents with morphine. (1998) (21)
The attenuation of learning impairments induced after exposure to CO or trimethyltin in mice by sigma (sigma) receptor ligands involves both sigma1 and sigma2 sites. (1999) (21)
Effects of sigma receptor agonists on the impairment of spontaneous alternation behavior and decrease of cyclic GMP level induced by nitric oxide synthase inhibitors in mice (2000) (21)
Alterations of regional γ-aminobutyric acid receptors in morphine tolerant mice (1981) (21)
Enhancement of immobility induced by repeated phencyclidine injection: association with c-Fos protein in the mouse brain (2001) (21)
Genes and Molecules That Can Potentiate or Attenuate Psychostimulant Dependence (2008) (21)
Betaine attenuates memory impairment after water‐immersion restraint stress and is regulated by the GABAergic neuronal system in the hippocampus (2017) (21)
Kynurenine 3-monooxygenase is implicated in antidepressants-responsive depressive-like behaviors and monoaminergic dysfunctions (2017) (20)
Absence of kynurenine 3-monooxygenase reduces mortality of acute viral myocarditis in mice. (2017) (20)
Technology and the prevention of surgical site infections. (2007) (20)
Phencyclidine-induced decrease of methionine-enkephalin levels in mouse brain. (1982) (20)
Functional Changes in Neuronal Systems Induced by Phencyclidine Administration a (1996) (20)
[Effects of administration of Clostridium butyricum to patients receiving long-term tube feeding]. (1997) (20)
Prophylaxis of Local Vascular Graft Infection with Levofloxacin Incorporated into Albumin‐Sealed Dacron Graft (LVFX‐ALB Graft) (1999) (20)
A cyclosporin A/maltosyl‐α‐cyclodextrin complex for inhalation therapy of asthma (2003) (20)
Lack of effect of Chinese medicines on bioavailability of ofloxacin in healthy volunteers. (1994) (20)
Alterations of Emotional and Cognitive Behaviors in Matrix Metalloproteinase-2 and -9-Deficient Mice (2010) (19)
RISK FACTORS FOR EXTENDED-SPECTRUM β-LACTAMASE-PRODUCING ESCHERICHIA COLI INFECTION IN HOSPITALIZED PATIENTS (2012) (19)
Analgesic and antiinflammatory effects of 2-(10,11-dihydro-10-oxo-dibenzo[b,f]thiepin-2-yl)propionic acid in rat and mouse. (1987) (19)
Distribution and serum concentration of sisomicin released from fibrin glue-sealed dacron graft in the rat and human. (2000) (19)
Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats. (1987) (19)
Pain relief of oral ulcer by dibucaine-film (1999) (19)
Calcium-dependent GABA release from mouse brain slices following acute and chronic phencyclidine administration (1981) (19)
The Effect of Lipopolysaccharide on the Disposition of Xanthines in Rats (1993) (19)
Sustained release of basic fibroblast growth factor from the synthetic vascular prosthesis using hydroxypropylchitosan acetate. (1995) (19)
Association of Lifelong Intake of Barley Diet with Healthy Aging: Changes in Physical and Cognitive Functions and Intestinal Microbiome in Senescence-Accelerated Mouse-Prone 8 (SAMP8) (2019) (19)
Structure‐pharmacokinetic Relationships among the N1, N3‐Alkylxanthines in Rats (1991) (19)
Effects of acute and chronic administrations of phencyclidine on the levels of serotonin and 5-hydroxyindoleacetic acid in discrete brain areas of mouse. (1985) (19)
Dextromethorphan-induced psychotoxic behaviors cause sexual dysfunction in male mice via stimulation of σ-1 receptors (2012) (19)
Neuropsychotoxicity of abused drugs: potential of dextromethorphan and novel neuroprotective analogs of dextromethorphan with improved safety profiles in terms of abuse and neuroprotective effects. (2008) (19)
The disposition and renal handling of enprofylline in endotoxemic rats by bacterial lipopolysaccharide (LPS). (1993) (19)
Effect of minaprine on cycloheximide-induced amnesia in mice. (1989) (19)
Exposure to far‐infrared ray attenuates methamphetamine‐induced impairment in recognition memory through inhibition of protein kinase C δ in male mice: Comparison with the antipsychotic clozapine (2018) (18)
Prenatal exposure to phencyclidine produces abnormal behaviour and NMDA receptor expression in postpubertal mice. (2010) (18)
Anatomical substrates for the discriminative stimulus effects of methamphetamine in rats (2004) (18)
Effects of oral administration of a stimulator for nerve growth factor synthesis in basal forebrain-lesioned rats. (1993) (18)
Exposure to Far Infrared Ray Protects Methamphetamine-Induced Behavioral Sensitization in Glutathione Peroxidase-1 Knockout Mice via Attenuating Mitochondrial Burdens and Dopamine D1 Receptor Activation (2018) (18)
Role of dopaminergic and serotonergic neuronal systems in the prefrontal cortex of rats in phencyclidine-induced behaviors. (1986) (18)
Two phases of behavioral plasticity in rats following unilateral excitotoxic lesion of the hippocampus (1999) (18)
Phencyclidine-induced head-weaving observed in mice after ritanserin treatment. (1987) (18)
Dimemorfan prevents seizures induced by the L-type calcium channel activator BAY k-8644 in mice (2004) (18)
Reinforcing effects of morphine are reduced in tissue plasminogen activator-knockout mice (2007) (18)
The effect of tacrine (THA) on cycloheximide- and basal forebrain lesion-induced memory deficit in rats. (1991) (18)
Age-related changes in learning and memory and cholinergic neuronal function in senescence accelerated mice (SAM) (1995) (18)
Electric footshock-induced changes in behavior and opioid receptor function (1985) (18)
Role of tissue plasminogen activator in the sensitization of methamphetamine‐induced dopamine release in the nucleus accumbens (2008) (18)
Phencyclidine interacts with serotonin2 receptor, but not serotonin1 receptor (1984) (18)
Thyrotoropin receptor knockout changes monoaminergic neuronal system and produces methylphenidate-sensitive emotional and cognitive dysfunction (2014) (18)
In vivo hypoxia-induced neuronal damage in dentate gyrus of rat hippocampus: changes in NMDA receptors and the effect of MK–801 (1997) (18)
The antagonistic effects of naloxone on cycloheximide and anisomicin-induced amnesia (1986) (18)
Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine on psychomotor function and histamine-induced wheal- and flare-responses: a randomized double-blind, placebo-controlled study in healthy volunteers (2011) (18)
Biliary and renal excretions of cefpiramide in Eisai hyperbilirubinemic rats (1995) (17)
Diisopropylfluorophosphate and GABA synaptic function: effect on levels, enzymes, release and uptake in the rat striatum. (1983) (17)
Characteristics of muscarinic cholinergic, γ-aminobutyric acidA and phencyclidine receptors in spontaneously epileptic rats; in vitro quantitative autoradiographic analysis (1991) (17)
Significance of protein kinase C in the neuropsychotoxicity induced by methamphetamine-like psychostimulants (2019) (17)
Dysfunction of Serotonergic and Dopaminergic Neuronal Systems in the Antidepressant-Resistant Impairment of Social Behaviors Induced by Social Defeat Stress Exposure as Juveniles (2018) (17)
Therapeutic potential of nicotine for methamphetamine-induced impairment of sensorimotor gating: involvement of pallidotegmental neurons (2009) (17)
Involvement of activation of dopaminergic neuronal system in learning and memory deficits associated with experimental mild traumatic brain injury. (1997) (17)
Oral administration of propentofylline, a stimulator of nerve growth factor (NGF) synthesis, recovers cholinergic neuronal dysfunction induced by the infusion of anti-NGF antibody into the rat septum (1997) (17)
Comparisons of cochleotoxicity among three gentamicin compounds following intratympanic application (2008) (17)
Kynurenine produced by indoleamine 2,3-dioxygenase 2 exacerbates acute liver injury by carbon tetrachloride in mice. (2020) (17)
Activation of post‐synaptic dopamine D1 receptors promotes the release of tissue plasminogen activator in the nucleus accumbens via PKA signaling (2007) (17)
PKCδ knockout mice are protected from para-methoxymethamphetamine-induced mitochondrial stress and associated neurotoxicity in the striatum of mice (2016) (17)
Effects of repeated administration of (−)-nicotine on AF64A-induced learning and memory impairment in rats (2002) (17)
Dose-dependent pharmacokinetics of enprofylline and its renal handling in rats. (1991) (16)
The role of system Xc− in methamphetamine-induced dopaminergic neurotoxicity in mice (2017) (16)
Effects of single and repeated administration of methamphetamine or morphine on neuroglycan C gene expression in the rat brain. (2006) (16)
Growth hormone-releaser diet attenuates beta-amyloid(1-42)-induced cognitive impairment via stimulation of the insulin-like growth factor (IGF)-1 receptor in mice. (2009) (16)
Linking phencyclidine intoxication to the tryptophan-kynurenine pathway: Therapeutic implications for schizophrenia (2019) (16)
Blockade of platelet-activating factor receptor attenuates abnormal behaviors induced by phencyclidine in mice through down-regulation of NF-κB (2018) (16)
New prospective payment system in Japan. (2005) (16)
Enhanced antidepressant efficacy of sigma1 receptor agonists in rats after chronic intracerebroventricular infusion of beta-amyloid-(1-40) protein. (2004) (16)
A novel molecule ‘shati’ increases dopamine uptake via the induction of tumor necrosis factor‐α in pheochromocytoma‐12 cells (2008) (16)
Involvement of the serotonergic neuronal system in phencyclidine-induced place aversion in rats (1999) (16)
[3H]Thienylcyclohexylpiperidine Binding Activity in Brain Synaptic Membranes Treated with Triton X‐100 (1990) (16)
Effects of dietary vegetable oils on behavior and drug responses in mice. (1996) (16)
Combination of neonatal PolyI:C and adolescent phencyclidine treatments is required to induce behavioral abnormalities with overexpression of GLAST in adult mice (2014) (16)
Theanine attenuates memory impairments induced by klotho gene depletion in mice. (2019) (16)
Effects of sigma receptor ligands on conditioned fear stress. (1998) (16)
Neuronal PAS domain protein 4 (Npas4) controls neuronal homeostasis in pentylenetetrazole‐induced epilepsy through the induction of Homer1a (2018) (16)
Development and evaluation of a novel dry-coated tablet technology for pellets as a substitute for the conventional encapsulation technology. (2007) (15)
Kainic acid lesion-induced spatial memory deficits of rats (2009) (15)
Nefiracetam Attenuates Methamphetamine‐Induced Discriminative Stimulus Effects in Rats (2004) (15)
Propentofylline prevents neuronal dysfunction induced by infusion of anti-nerve growth factor antibody into the rat septum. (1996) (15)
Mediation of dopamine D1 and D2 receptors in the effects of GBR 12909 on latent learning and locomotor activity in mice. (1993) (15)
Effect of morphine on the responses to and disposition of phencyclidine in mice. I. Enhancement of phencyclidine effects by acute morphine administration. (1983) (15)
Low dose of 1,3-di(2-tolyl)guanidine (DTG) attenuates MK-801-induced spatial working memory impairment in mice (1994) (15)
Deletion of SHATI/NAT8L decreases the N-acetylaspartate content in the brain and induces behavioral deficits, which can be ameliorated by administering N-acetylaspartate (2015) (15)
Chronic phencyclidine increases methionine-enkephalin level in mouse striatum (1983) (15)
Mountain-Cultivated Ginseng Attenuates Phencyclidine-Induced Abnormal Behaviors in Mice by Positive Modulation of Glutathione in the Prefrontal Cortex of Mice. (2016) (15)
Involvement of κ-opioid and σ receptors in short-term memory in mice (2002) (15)
The roles of MAGE-D1 in the neuronal functions and pathology of the central nervous system (2013) (15)
Renal excretion of famotidine and role of adenosine in renal failure induced by bacterial lipopolysaccharide in rats. (1994) (15)
Dose Adjustment Strategy for Oral Microemulsion Formulation of Cyclosporine: Population Pharmacokinetics-Based Analysis in Kidney Transplant Patients (2004) (15)
Time-dependent changes in the pharmacokinetics and renal excretion of xanthine derivative enprofylline induced by bacterial endotoxin in rats. (1995) (15)
Heat-sterilized Bifidobacterium breve prevents depression-like behavior and interleukin-1β expression in mice exposed to chronic social defeat stress (2021) (15)
[Factors influencing noncompliance with medication regimens in the elderly]. (2000) (15)
Determination of methionine-enkephalin, norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC) and 3-methoxy-4-hydroxyphenylacetic acid (HVA) in brain by high-pressure liquid chromatography with electrochemical detector. (1982) (15)
Effects of opiate agonists on the conditioned suppression in motility of mice (1983) (14)
Involvement of nitric oxide in phencyclidine-induced place aversion and preference in mice (2000) (14)
Inhibitory effect of difenamizole on morphine-induced straub tail reaction with special reference to monoaminergic agents. (1978) (14)
Effects of sodium houttuyfonate on phosphorylation of CaMK II, CREB and ERK 1/2 and expression of c-Fos in macrophages. (2004) (14)
Effects of Prescription Drug Reduction on Quality of Life in Community-Dwelling Patients with Dementia. (2015) (14)
Changes in extracellular nitrite and nitrate levels after inhibition of glial metabolism with fluorocitrate (1997) (14)
Astrocytic mobilization of glutathione peroxidase‐1 contributes to the protective potential against cocaine kindling behaviors in mice via activation of JAK2/STAT3 signaling (2019) (14)
Involvement of spinal and supraspinal structures in tizanidine-induced antinociceptive action (1986) (14)
Anticonvulsant actions of nefiracetam on epileptic EL mice and their relation to peripheral-type benzodiazepine receptors (2000) (14)
PKCδ Knockout Mice Are Protected from Dextromethorphan-Induced Serotonergic Behaviors in Mice: Involvements of Downregulation of 5-HT1A Receptor and Upregulation of Nrf2-Dependent GSH Synthesis (2018) (14)
Phencyclidine-induced expression of c-Fos-like immunoreactivity in mouse brain regions (1996) (14)
Brain Distribution Characteristics of Xanthine Derivatives and Relation to their Locomotor Activity in Mice (1995) (14)
Neurotrophic Factor Strategies for the Treatment of Alzheimer Disease (2000) (14)
Effects of NIK-247 on CO-induced impairment of passive avoidance in mice. (1992) (14)
The attenuation of suppression of motility by triazolam in the conditioned fear stress task is exacerbated by ethanol in mice. (1995) (14)
Effects of Kamikihito, a traditional Chinese medicine, on neurotransmitter receptor binding in the aged rat brain determined by in vitro autoradiography (2): changes in GABAA and benzodiazepine receptor binding. (1994) (13)
Interaction between enkephalinergic and dopaminergic systems in stressful situations. (1991) (13)
Behavioral characterization of mice overexpressing human dysbindin-1 (2014) (13)
Involvement of Signal Transduction Cascade via Dopamine‐D1 Receptors in Phencyclidine Dependence (2004) (13)
Antinociceptive activity induced by tizanidine and alpha 2-adrenoreceptors. (1987) (13)
Inhibition of protein kinase (PK) Cδ attenuates methamphetamine‐induced dopaminergic toxicity via upregulation of phosphorylation of tyrosine hydroxylase at Ser40 by modulation of protein phosphatase 2A and PKA (2015) (13)
A PERMISSION SYSTEM FOR CARBAPENEM USE REDUCED INCIDENCE OF DRUG-RESISTANT BACTERIA AND COST OF ANTIMICROBIALS AT A GENERAL HOSPITAL IN JAPAN (2012) (13)
Role of protein kinase Cδ in dopaminergic neurotoxic events. (2018) (13)
Measurement of dissociation of amnesic and behavioral effects of drugs in mice (1993) (13)
Glutathione Peroxidase-1 Knockout Facilitates Memory Impairment Induced by β-Amyloid (1–42) in Mice via Inhibition of PKC βII-Mediated ERK Signaling; Application with Glutathione Peroxidase-1 Gene-Encoded Adenovirus Vector (2020) (13)
Comparison of tizanidine and morphine with regard to tolerance-developing ability to antinociceptive action (1986) (13)
Alterations of synaptic high and low affinity opiate binding sites after acute and chronic morphine administration in mice (1982) (13)
Effects of prenatal and perinatal administration of phencyclidine on the behavioral development of rat offspring (1987) (13)
Acid load during total parenteral nutrition: comparison of hydrochloric acid and acetic acid on plasma acid-base balance. (2000) (13)
Possible involvement of the activation of voltage-sensitive calcium channels in the ameliorating effects of nefiracetam on scopolamine-induced impairment of performance in a passive avoidance task. (1994) (13)
Genetically modified mice harboring mitochondrial DNA defects show aberrant cyclic change in wheel-running activity, which is improved by lithium (2006) (13)
Differential effects of SH-reactive agents on [3H](±)-3-(2-carboxypiperazin-4-yl)propyl-1-phosphonate and [3H]glutamate binding in brain synaptic membranes treated with triton X-100 (1991) (13)
Effects of nerve growth factor (NGF) in rats with basal forebrain lesions. (1994) (13)
Potentiation of phencyclidine-induced dopamine-dependent behaviors in rats after pretreatments with serotonin-depletors. (1986) (13)
Plasma dehydroepiandrosterone sulfate levels in patients with major depressive disorder correlate with remission during treatment with antidepressants (2014) (13)
Reelin Supplementation Into the Hippocampus Rescues Abnormal Behavior in a Mouse Model of Neurodevelopmental Disorders (2020) (12)
Comparative absorption of 5-aminosalicylic acid (5-ASA) after administration of a 5-ASA enema and salazosulfapyridine (SASP) after an SASP suppository in Japanese volunteers. (2002) (12)
Differences of alteration in opioid systems induced by conditioned suppression and electric footshock in mice (1985) (12)
Changes in striatal dopamine release in stress-induced conditioned suppression of motility in rats (1996) (12)
Basic and translational research on proteinase-activated receptors: regulation of nicotine reward by the tissue plasminogen activator (tPA) - plasmin system via proteinase-activated receptor 1. (2008) (12)
Influence of a Bacterial Lipopolysaccharide on the Pharmacokinetics of Tobramycin in Rats (1993) (12)
Involvement of AChergic systems in chlordiazepoxide induced impairment of passive avoidance response (1990) (12)
PAP 9704, a Korean herbal medicine attenuates methamphetamine-induced hyperlocomotion via adenosine A2A receptor stimulation in mice. (2004) (12)
Changes in concentrations of dopamine, serotonin, and their metabolites induced by carbon monoxide (CO) in the rat striatum as determined by in vivo microdialysis (1994) (12)
Deletion of SHATI/NAT8L increases dopamine D1 receptor on the cell surface in the nucleus accumbens, accelerating methamphetamine dependence. (2014) (12)
Effects of vinconate, a novel vinca alkaloid, on spatial learning deficits induced by the basal forebrain lesion in rats (1992) (12)
Effects of metaphit on phencyclidine and serotonin2 receptors (1989) (12)
Oral administration of idebenone induces nerve growth factor in the brain and improves learning and memory in basal forebrain-lesioned rats (1994) (12)
Nefiracetam (DM-9384): A novel antiamnesic drug (1996) (12)
Indoleamine 2,3‐dioxygenase 2 depletion suppresses tumor growth in a mouse model of Lewis lung carcinoma (2019) (12)
Factors Affecting Ethanol-Induced Conditioned Place Preference and Locomotor Sensitization in Mice. (2015) (12)
D-Serine ameliorates neonatal PolyI:C treatment-induced emotional and cognitive impairments in adult mice. (2012) (12)
Studies on the Kinetics, Metabolism and Re-utilisation after Intra-articular Administration of Hyaluronan to Rabbits (1999) (12)
Effects of traditional Chinese medicines on pharmacokinetics of levofloxacin (1995) (12)
SHATI/NAT8L regulates neurite outgrowth via microtubule stabilization (2013) (12)
Dissociable role of tumor necrosis factor alpha gene deletion in methamphetamine self-administration and cue-induced relapsing behavior in mice (2012) (12)
Neuronal mechanisms of phencyclidine-induced place aversion and preference in the conditioned place preference task. (1998) (12)
Staurosporine, a protein kinase inhibitor, attenuates basal forebrain-lesion-induced amnesia and cholinergic neuronal deficit (1991) (11)
Growth hormone releaser attenuates beta-amyloid (1 - 42)-induced memory impairment in mice. (2005) (11)
Endorphins do not affect behavioral stress responses in mice (1992) (11)
Involvement of GABAergic systems in benzodiazepine-induced impairment of passive avoidance learning in mice (1991) (11)
No changes in cerebrospinal fluid levels of nitrite, nitrate and cyclic GMP with aging (2005) (11)
Naftidrofuryl oxalate, nootropic effects on the scopolamine- and the basal forebrain lesion-induced amnesia in rats (1991) (11)
IL-6 knockout mice are protected from cocaine-induced kindling behaviors; possible involvement of JAK2/STAT3 and PACAP signalings. (2018) (11)
Behavioral impairment in SHATI/NAT8L knockout mice via dysfunction of myelination development (2017) (11)
Involvement of opioid receptors in hypo- and hyperthermic effects induced by phencyclidine in mice. (1986) (11)
Valproic acid increases biliary copper excretion in the rat (2002) (11)
Galantamine attenuates reinstatement of cue‐induced methamphetamine‐seeking behavior in mice (2014) (11)
Prevention of Vascular Graft Infection by Sisomicin Incorporated into Fibrin Glue (1995) (11)
Modeling the Positive Symptoms of Schizophrenia (2016) (11)
Role of microsomal epoxide hydrolase in methamphetamine‐induced drug dependence in mice (2009) (11)
Mucosal immunotherapy in an Alzheimer mouse model by recombinant Sendai virus vector carrying Aβ1-43/IL-10 cDNA. (2011) (11)
Selective and competitive inhibition of kynurenine aminotransferase 2 by glycyrrhizic acid and its analogues (2019) (11)
Carvedilol increases ciclosporin bioavailability by inhibiting P‐glycoprotein‐mediated transport (2007) (11)
Different effects of ethylketocyclazocine on phencyclidine- and N-allylnormetazocine-induced stereotyped behaviors in rats (1987) (11)
Phencyclidine-induced retrograde amnesia in mice (1986) (11)
Antinociceptive action of tizanidine in mice and rats (1985) (11)
Induction of neuronal axon outgrowth by Shati/Nat8l by energy metabolism in mice cultured neurons (2015) (11)
[Neuropsychopharmacological study on an animal model for negative symptom of schizophrenia induced by repeated phencyclidine treatment]. (2000) (11)
626 Toxicity of β-amyloid protein: Neurochemical, histological and behavioral changes (1996) (11)
Involvement of different opioid receptor subtypes in electric shock-induced analgesia and motor suppression in the rat. (1985) (11)
Moderate-dose Regular Lifelong Alcohol Intake Changes the Intestinal Flora, Protects against Aging, and Keeps Spatial Memory in the Senescence-accelerated Mouse Prone 8 (SAMP8) Model. (2016) (11)
Role of dopamine D1 receptor in 3-fluoromethamphetamine-induced neurotoxicity in mice (2018) (11)
Hispidulin attenuates the social withdrawal in isolated disrupted‐in‐schizophrenia‐1 mutant and chronic phencyclidine‐treated mice (2020) (11)
Acute administration of ketamine attenuates the impairment of social behaviors induced by social defeat stress exposure as juveniles via activation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors (2019) (11)
Influence of endotoxin and lipid A on the renal handling and accumulation of gentamicin in rats. (1994) (11)
Latent copper deficiency in patients receiving low-copper enteral nutrition for a prolonged period. (2005) (11)
SKF-10,047 reverses stress-induced motor suppression: interaction with dopaminergic system. (1994) (10)
Effects of Gastrodia Elata Bl on Phencyclidine-Induced Schizophrenia-Like Psychosis in Mice (2011) (10)
EFFECT OF TRANSMUCOSAL FLUID MOVEMENT ON ZINC AND COPPER ABSORPTION FROM THE RAT SMALL INTESTINE (1998) (10)
Pharmaceutical evaluation of carbamazepine suppositories in rats. (1995) (10)
[Sigma-receptor ligands and anti-stress actions]. (1999) (10)
Involvement of the cholinergic neuronal system and benzodiazepine receptors in alcohol-induced amnesia. (1991) (10)
Microinjection of Reelin into the mPFC prevents MK-801-induced recognition memory impairment in mice. (2021) (10)
Effects of catecholaminergic or tryptaminergic agents on the morphine-induced Straub tail reaction. (1978) (10)
The involvement of brain-derived neurotrophic factor in 3,4-methylenedioxymethamphetamine-induced place preference and behavioral sensitization (2017) (10)
Effects of VA‐045 on learning and memory deficits in traumatic brain injury (TBI)‐induced retrograde and anterograde amnesic mice (1997) (10)
Role of the Clinical Pharmacist in Pharmaceutical Care (2005) (10)
Growth Hormone-Releaser Diet Attenuates Cognitive Dysfunction in Klotho Mutant Mice via Insulin-Like Growth Factor-1 Receptor Activation in a Genetic Aging Model (2014) (10)
Repetitive and compulsive‐like behaviors lead to cognitive dysfunction in Disc1Δ2‐3/Δ2‐3 mice (2018) (10)
Effects of (R)-(−)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride [(−)-BPAP] in animal models of mood disorders (2008) (10)
Silibinin Attenuates Amyloid (cid:1) 25–35 Peptide-Induced Memory Impairments: Implication of Inducible Nitric-Oxide Synthase and Tumor Necrosis Factor- (cid:2) in Mice (2009) (10)
Effects of the subacute administration of nefiracetam on abnormal behavior in aged rats (1996) (10)
A synergistic interaction between dopamine Dl and D2 receptor subtypes in the memory impairments induced by concussive brain injury (CBI) in mice (1997) (10)
Alzheimer's disease animal models induced by continuous infusion of ß-amyloid protein and anti-nerve growth factor antibody (1997) (10)
Evaluation of “Bronchial Asthma Pharmaceutical Care Clinic for Outpatients” Run by Pharmacists at Nagoya University Hospital (2006) (10)
Alterations in Renal Uptake Kinetics of the Xanthine Derivative Enprofylline in Endotoxaemic Mice (1996) (10)
GPx-1-encoded adenoviral vector attenuates dopaminergic impairments induced by methamphetamine in GPx-1 knockout mice through modulation of NF-κB transcription factor. (2021) (9)
Effects of DM-9384 and aniracetam on learning in normal and basal forebrain-lesioned rats (1991) (9)
Determination of N-acetylaspartic acid concentration in the mouse brain using HPLC with fluorescence detection. (2012) (9)
[PolyI:C-induced neurodevelopmental animal model for schizophrenia]. (2011) (9)
Shati/Nat8l deficiency disrupts adult neurogenesis and causes attentional impairment through dopaminergic neuronal dysfunction in the dentate gyrus (2020) (9)
Oral supplementation with Leu-Ile, a hydrophobic dipeptide, prevents the impairment of memory induced by amyloid beta in mice via restraining the hyperphosphorylation of extracellular signal-regulated kinase (2010) (9)
Vulnerability in early life to changes in the rearing environment plays a crucial role in the aetiopathology of psychiatric disorders. (2012) (9)
The interaction between the cholinergic and dopaminergic system in learning and memory process in rats. (2004) (9)
Alterations in the pharmacokinetics and protein binding of enprofylline in Eisai hyperbilirubinemic rats. (1994) (9)
The Piccolo Intronic Single Nucleotide Polymorphism rs13438494 Regulates Dopamine and Serotonin Uptake and Shows Associations with Dependence-Like Behavior in Genomic Association Study. (2015) (9)
[Experimental techniques for developing new drugs acting on dementia (10)--Alzheimer's disease animal model induced by beta-amyloid protein]. (1996) (9)
An adenoviral vector encoded with the GPx-1 gene attenuates memory impairments induced by β-amyloid (1-42) in GPx-1 KO mice via activation of M1 mAChR-mediated signalling (2020) (9)
Effects of 1,3-diphenyl-5-(2-dimethylaminopropionamide)-pyrazole[difenamizole] on a conditioned avoidance response. (1978) (9)
Impairment of active avoidance response in rats with continuous infusion of quinolinic acid into the lateral ventricle. (1991) (9)
MK‐801, but not naloxone, attenuates high‐dose dextromethorphan‐induced convulsive behavior: Possible involvement of the GluN2B receptor (2017) (9)
Potentiation of phencyclidine-induced stereotyped behaviors in rats by thiorphan and bestatin. (1986) (9)
Modulation of nitric oxide production in vivo in the brain. (1998) (9)
Structure-related inhibitory effect of quinolones on alkyl-xanthine elimination in rats. (1991) (9)
[Physiological function of sigma receptors: central pharmacological effects of sigma ligands]. (1994) (9)
Influence of a newly developed quinolone, T-3761, on pharmacokinetics of theophylline in rats (1995) (9)
Functional alteration of opioid receptor subtypes in the mice exhibited conditioned suppression in motility (1985) (9)
In vivo functional interaction between phencyclidine binding sites and sigma receptors to produce head-weaving behavior in rats. (1996) (9)
Prefrontal cortex miR‐874‐3p prevents lipopolysaccharide‐induced depression‐like behavior through inhibition of indoleamine 2,3‐dioxygenase 1 expression in mice (2020) (9)
5-HT1A receptor agonist 8-OH-DPAT induces serotonergic behaviors in mice via interaction between PKCδ and p47phox. (2019) (9)
Conformational changes of opioid receptor induced by the electric footshock (1985) (9)
[Impairment of learning and memory and the accessory symptom in aged rats as senile dementia model (1)--Emotional behavior]. (1993) (9)
Prodynorphin gene deficiency potentiates nalbuphine-induced behavioral sensitization and withdrawal syndrome in mice. (2009) (8)
A cyclosporin A/maltosyl-alpha-cyclodextrin complex for inhalation therapy of asthma. (2003) (8)
The Latent Risk of Acidosis in Commercially Available Total Parenteral Nutrition (TPN) Products: a Randomized Clinical Trial in Postoperative Patients (2009) (8)
Generation and analysis of novel Reln‐deleted mouse model corresponding to exonic Reln deletion in schizophrenia (2020) (8)
Memory impairment and morphological changes in rats after continuous infusion of active fragment of anti-nerve growth factor-antibody. (1991) (8)
The interaction of eptazocine, a novel analgesic, with opioid receptors. (1985) (8)
Development of tolerance to amnesic effects of chlordiazepoxide in relation to GABAergic and cholinergic neuronal systems. (1993) (8)
Pharmacokinetics and the effect of probenecid on the renal excretion mechanism of diprophylline. (1992) (8)
Pharmacokinetic and pharmacodynamic properties of some phencyclidine analogs in rats (1991) (8)
Hypoglycemia in mice exposed to an environment of high temperature and humidity. (1981) (8)
[The mechanisms of morphine dependence and it's withdrawal syndrome: study in mutant mice]. (2001) (8)
Organophosphate agent induces ADHD-like behaviors via inhibition of brain endocannabinoid-hydrolyzing enzyme(s) in adolescent male rats. (2020) (8)
The ubiquitination of serotonin transporter in lymphoblasts derived from fluvoxamine-resistant depression patients (2016) (8)
Effects of metrifonate on impairment of learning and dysfunction of cholinergic neuronal system in basal forebrain-lesioned rats (1997) (8)
Granulocyte Colony-Stimulating Factor Enhances Endotoxin-Induced Decrease in Biliary Excretion of the Antibiotic Cefoperazone in Rats (1998) (8)
Protection with phencyclidine against inactivation of 5-HT2 receptors by sulfhydryl-modifying reagents. (1988) (8)
Indoleamine-2,3-dioxygenase-1 is a molecular target for the protective activity of mood stabilizers against mania-like behavior induced by d-amphetamine. (2019) (7)
Phencyclidine-induced stereotyped behaviors after injection of morphine and N-allylnormetazocine (SKF 10,047) in rats (1986) (7)
Morphine-induced Straub tail reaction and spinal catecholamine metabolite content: antagonism of naloxone to morphine-induced effects in mice. (1978) (7)
Irinotecan Therapy in a 12-year-old Girl with Recurrent Brain Stem Glioma and without Functional Polymorphisms in UGT1A1 Activity: Case Report (2005) (7)
Intrastriatal gene delivery of GDNF persistently attenuates methamphetamine self-administration and relapse in mice. (2013) (7)
Effect of dizocilpine (MK-801) on the catalepsy induced by Δ9-tetrahydrocannabinol in mice (1994) (7)
Anticancer effects of adriamycin-loaded hydroxyapatite implants determined in a Swarm rat chondrosarcoma model. (1994) (7)
Pharmacokinetic characteristics of N7-substituted theophylline derivatives and their interaction with quinolone in rats. (1991) (7)
Different changes by acute electric footshock of opioid agonist and antagonist receptors in rat brain (1984) (7)
Difference in toxicity of β-amyloid peptide with aging in relation to nerve growth factor content in rat brain (2001) (7)
Adolescent stress leads to glutamatergic disturbance through dopaminergic abnormalities in the prefrontal cortex of genetically vulnerable mice (2017) (7)
PS141. Depressive Symptoms, as a side effect of Interferon-α therapy induced by induction of indoleamine 2,3-dioxygenase 1 (2016) (7)
Mice carrying a schizophrenia-associated mutation of the Arhgap10 gene are vulnerable to the effects of methamphetamine treatment on cognitive function: association with morphological abnormalities in striatal neurons (2021) (7)
Effects of kamikihito, a traditional Chinese medicine, on neurotransmitter receptor binding in the aged rat brain determined by in vitro autoradiography: changes in dopamine D1 and serotonin 5-HT2A receptor binding. (1994) (7)
[Pharmacological action of eptazocine (l-1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-banzazonine). (II) Relationship between the analgesic action of eptazocine and brain 5-hydroxytryptamine (5-HT) (author's transl)]. (1981) (7)
Effects of acute and chronic administration of phencyclidine on the levels of dopamine and metabolites in discrete brain areas of mouse (1983) (7)
Development of plasticity of brain function with repeated trainings and passage of time after basal forebrain lesions in rats (1993) (7)
Innate immune activation of astrocytes impairs neurodevelopment via upregulation of follistatin-like 1 and interferon-induced transmembrane protein 3 (2018) (7)
Effects of subacute administration of methamphetamine and nicotine on locomotor activity in transgenic mice expressing the human tyrosine hydroxylase gene (2005) (7)
[The psychological stress model using motor suppression]. (1999) (7)
[Cognition impairment in the klotho gene mutant mice and oxidative stress]. (2003) (7)
Our bright future: international collaboration in pharmacy. (2008) (7)
Effect of naftidrofuryl oxalate on 5-HT2 receptors in mouse brain: evaluation based on quantitative autoradiography and head-twitch response. (1992) (7)
[Evaluation of the symptoms, adherence and satisfaction after pharmaceutical care at asthma clinic for outpatient]. (2011) (7)
Phencyclidine-induced dopamine-dependent behaviors in chronic haloperidol-treated rats (1985) (6)
Effect of chlorphentermine on the pulmonary disposition of norepinephrine in the isolated perfused rabbit lung. (1981) (6)
Glutathione peroxidase-1 knockout potentiates behavioral sensitization induced by cocaine in mice via σ-1 receptor-mediated ERK signaling: A comparison with the case of glutathione peroxidase-1 overexpressing transgenic mice (2020) (6)
Relationship between anti-aversive effects of salmon calcitonin and plasma levels of ACTH, beta-endorphin and prostaglandin E2 in mice. (1994) (6)
Buserelin acetate microparticle dispersion effects drug release and plasma E(1) levels. (2007) (6)
Dm-9384, a Pyrrolidone Derivative, Ameliorates Basal Forebrain Lesion-Induced Amnesia and Inhibits Cycloheximide-Induced Decrease in the Number of GABA and Acetylcholine Receptors (1990) (6)
Conditioned suppression and opioid kappa receptor in mice. (1986) (6)
[Nerve growth factor strategy and preparation of animal model for Alzheimer-type senile dementia]. (1995) (6)
Protective potentials of far-infrared ray against neuropsychotoxic conditions (2019) (6)
[Development of animal models for schizophrenia based on clinical evidence: expectation for psychiatrists]. (2009) (6)
Induction of interferon-induced transmembrane protein 3 gene expression by lipopolysaccharide in astrocytes. (2014) (6)
(+)-Eburnamenine-14-carboxylic acid (2-nitroxyethyl) ester (VA-045), a putative cognitive enhancer, facilitates recovery from concussive brain injury-induced learning and memory impairments in mice (1997) (6)
[Possible relation of BDNF and GDNF to neuropsychiatric disorders]. (2009) (6)
Effects of phencyclidine in combination with morphine on the levels of met-enkephalin, dopamine, DOPAC and HVA in discrete brain areas of mice (1985) (6)
Evalulation of Activities Conducted by Pharmaceutical Care Clinic with Respect to Outpatient Inhalation Treatment (2009) (6)
Attenuation of benzodiazepine-induced passive avoidance deficit by post-training administration of muscimol: interaction with the cholinergic neuronal system. (1990) (6)
Shati/Nat8l knockout mice show behavioral deficits ameliorated by atomoxetine and methylphenidate (2018) (6)
Neuronal mechanism of the inhibitory effect of calcitonin on N-methyl-D-aspartate-induced aversive behavior. (1995) (6)
Attenuation of pharmacological effects and increased metabolism of phencyclidine in morphine tolerant mice. (1984) (6)
Mizuno, M. et al. Phosphatidylinositol 3-kinase: a molecule mediating BDNF-dependent spatial memory formation. Mol. Psychiatry 8, 217-224 (2003) (6)
[Impairment of learning and memory and the accessory symptom in aged rats as senile dementia model (2)--Learning and memory]. (1993) (6)
Overexpression of astroglial major histocompatibility complex class I in the medial prefrontal cortex impairs visual discrimination learning in mice (2020) (6)
Nociceptin and its metabolite attenuate U0126-induced memory impairment through a nociceptin opioid peptide (NOP) receptor-independent mechanism (2010) (6)
Clozapine attenuates mitochondrial burdens and abnormal behaviors elicited by phencyclidine in mice via inhibition of p47 phox ; Possible involvements of phosphoinositide 3-kinase/Akt signaling (2018) (6)
Effects of BMY-21502 on anoxia in mice. (1993) (6)
The Effects of N‐Benzoyl‐β‐alanine, a New Nephroprotective Drug, on the Distribution and Renal Excretion of Enprofylline in Rats (1993) (6)
Involvement of serotonergic neuronal systems in the anti-amnesic action of naftidrofuryl oxalate. (1992) (6)
Kynurenine 3-monooxygenase deficiency induces depression-like behavior via enhanced antagonism of α7 nicotinic acetylcholine receptors by kynurenic acid (2021) (6)
Effect of acute or chronic pentobarbital administration on the steady state levels and the turnover rates of catecholamines in discrete brain areas of mice. (1981) (6)
Decreased DNA Methylation in the Shati/Nat8l Promoter in Both Patients with Schizophrenia and a Methamphetamine-Induced Murine Model of Schizophrenia-Like Phenotype (2016) (6)
Analysis of Reelin signaling and neurodevelopmental trajectory in primary cultured cortical neurons with RELN deletion identified in schizophrenia (2020) (6)
[Experimental techniques for developing new drugs acting on dementia (6)--Carbon monoxide-induced amnesia model in experimental animals]. (1994) (5)
Pharmacists May Play a Role in Improving QOL and Reducing Medical Costs in the Psychiatric Ward (2005) (5)
Poster Presentations (2020) (5)
Elimination kinetics of quinaprilat and perindoprilat in hypertensive patients with renal failure on haemodialysis. (2003) (5)
Ginsenoside Re Protects against Serotonergic Behaviors Evoked by 2,5-Dimethoxy-4-iodo-amphetamine in Mice via Inhibition of PKCδ-Mediated Mitochondrial Dysfunction (2021) (5)
Opioid κ receptors correlate with the development of conditioned suppression of motility in mice (1988) (5)
Effects of acute and continuous administration of pentobarbital on phencyclidine response (1981) (5)
Nootropic effect of nicotine on carbon monoxide (CO)-induced delayed amnesia in mice (1994) (5)
Competitive NMDA antagonists enhance the catalepsy induced by Δ 9-tetrahydrocannabinol in mice (1994) (5)
[Analysis of neuronal functions in mice lacking the NMDA receptor epsilon 1 subunit]. (2002) (5)
TOXICITY OF β-AMYLOID PEPTIDE (1998) (5)
Pharmacokinetic model of oral levodopa and role of carbidopa in parkinsonian patients. (1995) (5)
Prefrontal cortex, dorsomedial striatum, and dentate gyrus are necessary in the object-based attention test in mice (2020) (5)
Pain Assessment for Cancer Patients Based on Their Pain Descriptions (Part 1) : Development and Evaluation of Methods of Pain Assessment (2006) (5)
Cell type-specific activation of mitogen-activated protein kinase in D1 receptor-expressing neurons of the nucleus accumbens potentiates stimulus-reward learning in mice (2018) (5)
Antitumor effects and distribution of adriamycin incorporated into hydroxyapatite implants in a cancer rat model bearing swarm rat chondrosarcoma. (1994) (5)
Nerve growth factor content of rat brain increases following basal-forebrain lesions induced by ibotenic acid but not by electrolysis. (1994) (5)
Studies on biogenic amines and behavior (I). Relationship between brain monamines and defecation in rats (1975) (4)
The effect of naftidrofuryl oxalate (LS-121) on learning and memory (1987) (4)
Role of dopaminergic neuronal system in dizocilpine-induced acetylcholine release in the rat brain (2005) (4)
Nerve Growth Factor and Staurosporine Facilitate Recovery from Basal Forebrain Lesion-Induced Amnesia in Rats (1990) (4)
[Relationship between biogenic amines and analgesic action of difenamizole in heat induced reflexes]. (1976) (4)
Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson’s disease (2021) (4)
Alpha 7-type nicotinic acetylcholine receptor and prodynorphin mRNA expression after administration of (-)-nicotine and U-50,488H in beta-amyloid peptide (25-35)-treated mice. (2004) (4)
Survey of Administration Methods for Powdered Medicines and Effectiveness of Medication Instruction in Improving Compliance in Pediatric Patients (2005) (4)
The inhibitory effects of salmon calcitonin on intrathecally-injected N-methyl-D-aspartate-induced aversive behavior in mice. (1993) (4)
Correlation between the 5-hydroxytryptamine contents in the brain and degrees of sensory, and locomotor activities in the rat. (1975) (4)
Fos Expression Associated with the Discriminative Stimulus Effects of Methamphetamine in Rats (2004) (4)
High-dose dextromethorphan produces myelinoid bodies in the hippocampus of rats. (2016) (4)
Implementation and evaluation of a once-daily amikacin dosing protocol in a long-term care facility. (2007) (4)
Skin tests of a novel nicotine patch, PHK-301p, in healthy male volunteers: phase I, placebo-controlled study. (2006) (4)
Neurochemical studies of an analgesic, 1,3-diphenyl-5-(2-dimethylaminopropionamide)-pyrazole [difenamizole]. (1981) (4)
[Learning/memory and drug dependence]. (2002) (4)
Targeting α6GABAA receptors as a novel therapy for schizophrenia: A proof-of-concept preclinical study using various animal models. (2022) (4)
Role of catecholaminergic and cyclic AMP systems in psychological dependence on phencyclidine: a study in mutant mice. (2000) (4)
Effect of tizanidine on body temperature in the mouse. (1986) (4)
MECHANISM OF TOLERANCE DEVELOPMENT TO PENTOBARBITAL IN RELATION TO GABA-ERGIC NEURONAL AND DISPOSITIONAL FUNCTIONS IN MICE (1983) (4)
[Trial to produce animal model of Alzheimer's disease by continuous infusion of beta-amyloid protein into the rat cerebral ventricle]. (1995) (4)
Toxicity of beta-amyloid peptide. (1998) (4)
Hypothermic and anti-inflammatory effects of Tizanidine (1985) (4)
[Neuropharmacological effects of sigma receptor ligands: anxiolytic, anti-amnesic and neuroprotective effects]. (1996) (4)
Piccolo regulates dopamine transporter internalization via PIP2 (2008) (4)
Effects of naftidrofuryl oxalate on the co-induced acute and delayed amnesia (1989) (4)
Effects of kamikihito, a traditional Chinese medicine, on neurotransmitter receptor binding in the aged rat brain determined by in vitro autoradiography (1): Changes in the [3H]QNB binding. (1994) (4)
Progranulin depletion inhibits proliferation via the transforming growth factor beta/SMAD family member 2 signaling axis in Kasumi-1 cells (2021) (3)
Verification of Effectiveness of Early Exposure Program in Enhancing Learning Motivation and Influence on Career Path at Faculty of Pharmacy, Meijo University (2011) (3)
[Behavioral assessment of neuroleptics (3)--Schizophrenia negative symptoms-like model induced by PCP]. (1996) (3)
Roles of a Novel Molecule ‘Shati’ in the Development of Methamphetamine-Induced Dependence (2011) (3)
Decreased l-tryptophan concentration in distinctive brain regions of mice treated repeatedly with phencyclidine (2013) (3)
Pharmacological blockade of dopamine D1- or D2-receptor in the prefrontal cortex induces attentional impairment in the object-based attention test through different neuronal circuits in mice (2021) (3)
[Effects of phencyclidine, the drug induces psychosis on the central nervous system]. (1986) (3)
Nootropic Nefiracetam Inhibits Proconvulsant Action of Peripheral‐Type Benzodiazepines in Epileptic Mutant EL Mice (2004) (3)
Long-lasting impairment of associative learning is correlated with a dysfunction of NMDA-ERK signaling in mice following withdrawal from repeated administration of phencyclidine. (2005) (3)
[Mucosal immunotherapy for alzheimer's disease with viral vectors]. (2007) (3)
Nicotine Ameliorates Emotional and Cognitive Impairments Induced byNeonatal PolyI:C Treatment in Mice (2010) (3)
Outpatient Pharmaceutical Care-Warfarin Classroom-. (2003) (3)
Development of tolerance to anxiolytic effects of chlordiazepoxide in elevated plus-maze test and decrease of GABAA receptors (1993) (3)
Responses of the pituitary-adrenal system of mice to an environment of high temperature and humidity. (1983) (3)
Studies on biogenic amines and behavior (II). Relationship between emotionality and defecation (1975) (3)
The relationship between phencyclidine-induced stereotyped behavior and dopamine release using in vivo voltammetry (1988) (3)
Immunohistochemical study of vesicle monoamine transporter 2 in the hippocampal formation of PCP-treated mice (2010) (3)
Phencyclidine-induced stereotyped behaviors after injection of ethylketocyclazocine, Mr 2266 and naltrexone in rats (1986) (3)
Secretion of ofloxacin into saliva in patients with respiratory tract infection. (1992) (3)
[Dysfunction of glutamatergic systems and potential animal models of schizophrenia]. (2006) (3)
Preparation of Work Sheets to Support Pharmaceutical Management in Cancer Chemotherapy for Outpatients-Project of 5 th chapter of Oncology Research Group, Aichi Prefectural Society of Hospital Pharmacists- (2006) (3)
ω-Conotoxin GVIA inhibits the methylphenidate-induced but not methamphetamine-induced behavior (1994) (3)
Involvement of kappa-opioid and sigma receptors in short-term memory in mice. (2002) (3)
Effects of Oral Calcium Dosage and Timing on Ethanol-Induced Sensitization of Locomotion in DBA/2 Mice. (2018) (3)
[Neuroactive steroid and stress response]. (2001) (3)
Effect of tooth loss on spatial learning and memory abilities in adult rats: Implications for central acetylcholine (1995) (3)
Cross sensitization between phencyclidine and methamphetamine. II: Repeated administration of methamphetamine at a high dose (1989) (3)
Acute and chronic effects of pentobarbital on 5-hydroxytryptamine in mouse brain. (1981) (3)
Ouabain inhibitor rostafuroxin attenuates dextromethorphan-induced manic potential. (2021) (3)
[Behavioral pharmacological characterization of mice lacking the nociceptin receptor]. (1999) (3)
Structure-related pharmacokinetics of xanthines after direct administration into the peritoneal cavity of rats. (1997) (3)
Pharmacokinetics and renal handling of enprofylline in pregnant rats. (1992) (3)
Effects of 5-HT(1A) receptor agonists on the passive avoidance task in mice (1992) (3)
Comparison of the Effects of a Brand-name Drug and Its Generic Drug on the Quality of Life of Alzheimer’s Disease Patients (2015) (3)
[Effect of monoamine-related drugs on inhibitory action of difenamizole to acetic acid-induced writhing in mice (author's transl)]. (1977) (2)
Effect of a single injection of psychoactive drugs on CCK mRNA in rat brain (1994) (2)
[Behavioral pharmacological action of Ca-4-(3,5-dihydroxy-3-methylpenthylamido) butyrate (mevalonic GABA, MV-GABA)]. (1987) (2)
Erratum: β-Amyloid protein-induced Alzheimer's disease animal model (Neuroscience Letters (1994) 170 (63-66)) (1994) (2)
Numerous GABAergic Afferents to Locus Ceruleus in the Pericerulear Dendritic Zone : Possible (2004) (2)
Clinical Potential of Compounds That Stimulate Nerve Growth Factor Production (1998) (2)
Mice with exonic RELN deletion identified from a patient with schizophrenia have impaired visual discrimination learning and reversal learning in touchscreen operant tasks (2021) (2)
Comparison of Roles of Hospital Infection Control Pharmacists in Japan and the United States (2006) (2)
Prevention of bone loss by percutaneous estradiol implants in ovariectomized rats. (1995) (2)
Cutaneous Adverse Reactions in a Patient Treated with Gefitinib (Iressa) (2004) (2)
Effects of nefiracetam, DM-9384 on amnesia and decrease in cholineacetyltransferase activity induced by cycloheximide (1992) (2)
Simultaneous determination of phencyclidine and its major metabolites in biological samples by high-performance liquid chromatography (1985) (2)
Neuroprotective and antiamnesic effects of NMDA antagonists (1991) (2)
[Recent topics of phencyclidine, the drug induces psychosis]. (1987) (2)
[Detection of auditory impairment in the offsprings caused by drug treatment of the dams]. (1982) (2)
[Neuroprotective effects of magnesium on cerebral ischemia and cerebral contusion]. (2004) (2)
Galantamine improves enhanced impulsivity, impairments of attention and long-term potentiation induced by prenatal nicotine exposure to mice. (2020) (2)
Clinical application of the Biotrack 516 system for determination of theophylline by a turbidimetric latex agglutination inhibition reaction. (1996) (2)
INVOLVEMENT OF GABA IN THE ACUTE AND CHRONIC EFFECTS OF MORPHINE:NOCICEPTIVE GABA RELEASE AND RECEPTOR BINDING STUDIES (1981) (2)
Nefiracetam induces a long-lasting facilitation of hippocampal postsynaptic responses in mice lacking the NMDA receptor ϵ1 subunit (2002) (2)
Influence of Housing Systems on Physical, Emotional, and Cognitive Functions with Aging in DBA/2CrSlc Mice (2020) (2)
[Pharmacological action of eptazocine (l-1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benz azonine). (V). A comparison of eptazocine, pentazocine and morphine with regard to ability of tolerance development after successive administration]. (1986) (2)
Involvement of dopaminergic system in the nucleus accumbens in the discriminative stimulus effects of phencyclidine (2002) (2)
INTERACTION BETWEEN MORPHINE AND PHENCYCLIDINE: INTOXICATION AND CROSS-TOLERANCE (1981) (2)
Synthesis and preliminary evaluation of [11C]NE-100 labeled in two different positions as a PET sigma receptor ligand. (1998) (2)
Recovery and maintenance of copper levels in geriatric patients on enteral feeding for a prolonged period. (2006) (2)
Ginsenoside Re attenuates memory impairments in aged Klotho deficient mice via interactive modulations of angiotensin II AT1 receptor, Nrf2 and GPx-1 gene. (2022) (2)
Prefrontal cortex miR-874-3p prevents lipopolysaccharide-induced depression-like behavior through inhibition of indoleamine 2,3-dioxygenase 1 expression in mice (2021) (2)
Preventive role of regular low-intensity exercise during adolescence in schizophrenia model mice with abnormal behaviors. (2020) (2)
[Possible mechanism of morphine-induced Straub tail reaction (STR) (author's transl)]. (1979) (2)
Corrigendum to ``Effects of metrifonate on memory impairment and cholinergic dysfunction in rats'' [Eur. J. Pharmacol. 322 (1997) 11–19] (1997) (2)
Effect of dizocilpine (MK-801) on the catalepsy induced by delta 9-tetrahydrocannabinol in mice. (1994) (2)
New therapeutic approaches to Alzheimer’s disease (2001) (2)
Loureirin C and Xanthoceraside Prevent Abnormal Behaviors Associated with Downregulation of Brain Derived Neurotrophic Factor and AKT/mTOR/CREB Signaling in the Prefrontal Cortex Induced by Chronic Corticosterone Exposure in Mice (2022) (2)
The Effect of the Contribution of Clinical Research Coordinators in Clinical Trials at the Nagoya University Hospital (2002) (2)
Carbon Monoxide (CO)-Induced Delayed Amnesia and Delayed Neuronal Death (1990) (2)
Phencyclidine, the drug induces psychosis: Its neuropharmacological actions (1984) (2)
[Pharmacy students' participation in medicinal education for children]. (2010) (2)
Effects of central muscle relaxants on the morphine-induced Straub tail reaction. (1977) (2)
Study on Changes in Form and Color of Orally Disintegrating Brotizolam Tablets after Dispensing by an Automatic Packaging Machine and Patient Preference with Regard to This Type of Tablet (2005) (2)
Inhibitory effects of salmon calcitonin on the tail-biting and scratching behavior induced by substance P and three excitatory amino acids (1994) (2)
Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice. (1994) (2)
Phencyclidine-induced wet-dog shakes observed in rats after withdrawal from reserpine treatment (1986) (2)
The relationship between brain γ-aminobutyric acid and plasma corticosterone levels in mice exposed to high ambient temperature or dexamethasone (1983) (2)
Research and Countermeasure to Unreceived Medicines in Nagoya University Hospital. (1993) (2)
[The 1998 domestic state of development of cognitive enhancers]. (1999) (2)
Influence of Age on the Disposition and Renal Handling of Enprofylline in Rats (1994) (1)
Efficacy of Unapproved Drug Temozolomide in Patients with Recurrent Malignant Glioma (2005) (1)
Novel therapeutic strategies of Alzheimer’s disease (1998) (1)
[Pesticide and central nervous system]. (2003) (1)
Potentiation of phencyclidine- and serotonin agonist-induced behaviors after administration of p-chloroamphetamine in rats (1989) (1)
Prenatal Nicotine Exposure and Impact on the Behaviors of Offspring (2019) (1)
A role played by sigma receptors in the conditioned suppression of motility in mice (1988) (1)
Effects of morphine administration on opiate receptor binding in mice (1981) (1)
Prenatal Nicotine Exposure and Neuronal Progenitor Cells (2019) (1)
PT563. Prenatal nicotine exposure impairs the proliferation of neuronal progenitors, leading to fewer glutamatergic neurons in the medial prefrontal cortex (2016) (1)
Requests from hospital pharmacists to research laboratories of pharmaceutical companies (2005) (1)
Clinical Effects of Gargle Containing Varidase and Xylocaine on Stomatitis induced by Cancer Chemotherapy. (1999) (1)
259 Neuronal dysfunction in rats infused β-amyloid protein into cerebral ventricle (1996) (1)
[Toxicity of carbon monoxide on the central nervous system: special reference to amnesia]. (1996) (1)
[Effects of difenamizole on behavior maintained by schedule of positive reinforcement (author's transl)]. (1977) (1)
Carbon Monoxide-Induced Impairment of Learning, Memory, and Neuronal Dysfunction (2019) (1)
Erratum to “Effects of memantine and donepezil on amyloid β-induced memory impairment in a delayed-matching to position task in rats” [Behav. Brain Res. 162 (2005) 191–199] (2006) (1)
Enhancement of phencyclidine (PCP) effects by acute and chronic morphine administration in mice (1981) (1)
Pain Assessment for Cancer Patients Based on Their Pain Descriptions (part 2)-Preliminary Study for Selecting Adequate Analgesics and Adjuvant Analgesics using APQ- (2006) (1)
[Behavioral evaluation in animal models of schizophrenia]. (2007) (1)
Dose response of DNA and RNA synthesis to pentobarbital (1983) (1)
[Phencyclidine abuse, dependence, intoxication, and psychosis]. (2010) (1)
Decrease of intensity in phencyclidine-induced place aversion in rats treated with subacute phencyclidine (1995) (1)
Effects of Dexamethasone on Nausea and Vomiting Induced by Gynecological Chemotherapy (2006) (1)
Conditioned suppression of motility: possibility for evaluation of learning and memory in mice. (1988) (1)
Continuous infusion of β-amyloid into the cerebral ventricle of rats promotes expression of BDNF messenger RNA in the hippocampus (1998) (1)
[Effects of sigma receptor ligands on psychiatric disorders]. (2003) (1)
Prenatal phencyclidine treatment induces behavioral deficits through impairment of GABAergic interneurons in the prefrontal cortex (2016) (1)
Early postnatal inhibition of GLAST causes abnormalities of psychobehaviors and neuronal morphology in adult mice (2021) (1)
Effect of phencyclidine (PCP) administration on GABA system (1981) (1)
Phencyclidine-induced cognitive impairment and its neural mechanisms (2014) (1)
[Effect of Non-alcoholic Beverage Intake in Children on Alcoholic Beverage Drinking and Smoking]. (2018) (1)
Effects of difenamizole on the emotionality in experimental animals (1977) (1)
Molecular mechanism of cholinergic dysfunction and cognitive deficits induced by amyloid beta-peptide. (2001) (1)
PM377. Role of glutathione peroxidase-1 gene in the phencyclidine-induced schizophrenia-like psychosis in mice (2016) (1)
Protective Potential of the Glutathione Peroxidase-1 Gene in Abnormal Behaviors Induced by Phencyclidine in Mice (2016) (1)
[Measurement of an auditory impairment induced by aminoglycosides using a shuttle box method in newborn rats]. (1985) (1)
CHAPTER 14:Beneficial Effects of Betaine on Water-Immersion Restraint Stress-Induced Memory Impairment in Mice (2015) (1)
S-46-4 Interactions between NMDA/Nitric oxide systems and σ receptors in learning and memory in mice (1996) (1)
Duloxetine attenuates pain in association with downregulation of platelet serotonin transporter in patients with burning mouth syndrome and atypical odontalgia (2021) (1)
Lithium attenuates d‐amphetamine‐induced hyperlocomotor activity in mice via inhibition of interaction between cyclooxygenase‐2 and indoleamine‐2,3‐dioxygenase (2019) (1)
[Behavioral approaches for analyzing emotionality in mutant mice]. (2005) (1)
[Measurement by in vivo brain dialysis of nitrite and nitrate levels as indices of nitric oxide production]. (2000) (1)
[Pharmacological action of eptazocine (l-1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benzazonine). (I). Relationship between the analgesic action of eptazocine and brain catecholamine (author's transl)]. (1981) (1)
Effects of various amino acids and their related agents in association with neurotransmitter substances on the morphine-induced Straub tail reaction in mice. (1978) (1)
PT687. Dextromethorphan-induced serotonin syndrome requires activation of protein kinase C- d gene. (2016) (1)
[Toxicity of fenfluramine to the central nervous system]. (2002) (1)
Loureirin C and Xanthoceraside Attenuate Depression-Like Behaviors and Expression of Interleukin-17 in the Prefrontal Cortex Induced by Chronic Unpredictable Mild Stress in Mice (2022) (1)
[Phencyclidine, a drug which induces psychosis: its neuropharmacological actions]. (1984) (1)
Tissue plasminogen activator is not involved in methamphetamine-induced neurotoxicity. (2008) (1)
Effects of outside air temperature on the preparation of antineoplastic drug solutions in biological safety cabinets (2015) (1)
PT688. PKCδ gene facilitates cognitive impairment induced by low doses of methamphetamine (MA) in mice (2016) (1)
Ginsenoside Re Rescues Methamphetamine-Induced Oxidative Damage, Mitochondrial Dysfunction, Microglial Activation, and Dopaminergic Degeneration by Inhibiting the Protein Kinase Cδ Gene (2014) (1)
LEARNING IMPROVING EFFECTS OF IDEBENONE(IDE) A STIMULATOR FOR NERVE GROWTH FACTOR SYNTHESIS IN BASAL FOREBRAIN(BF) LESIONED RATS. (1992) (1)
Effects of various drugs on morphine induced Straub response in mice (II). The relationship between GABA derivatives and tail response (1976) (1)
Effects of the inhibition of nitric oxide synthase on learning and memory in rats (1994) (1)
Effect of salmon calcitonin on the lethality of quinolinic acid, an excitatory amino acid. (1992) (1)
[Evaluation of latent learning in a water-finding test by using model animals]. (2007) (1)
Calcium dependent gamma amino butyric acid release from brain slices of morphinized mice (1982) (1)
Mice deficient in protein tyrosine phosphatase receptor type Z (PTPRZ) show reduced responsivity to methamphetamine despite an enhanced response to novelty (2019) (1)
Design of a phencyclidine implantation pellet; suitable for tolerance development. (1984) (1)
Piccolo as a regulator of behavioral plasticity and dopamine transporter internalization (2009) (1)
The Effect of Outpatient Prescription Ordering on Stocks of Unclaimed Prescribed Medications. (1993) (1)
Valosin-containing protein (VCP) is a novel IQ motif-containing GTPase activating protein 1 (IQGAP1)-interacting protein. (2017) (1)
Effect of acute and chronic administrations of pentobarbital on calcium-dependent GABA release from mouse brain slices (1982) (0)
1903 Behavioral and neurochemical evidences that w-conotoxin gvia inhibits the striatal dopamine release in vivo (1993) (0)
Possible mechanism of the morphine-induced Straub tail reaction (I) - with special reference to the spinal cord in mice (1978) (0)
[A method for evaluating visual impairments using operant behavior in mice]. (1986) (0)
PM346. Social defeat stress as juveniles impairs persistent social behaviors and neurogenesis (2016) (0)
PKCδ Knockout Mice Are Protected from Dextromethorphan-Induced Serotonergic Behaviors in Mice: Involvements of Downregulation of 5-HT1A Receptor and Upregulation of Nrf2-Dependent GSH Synthesis (2018) (0)
High salt induces cognitive impairment via the angiotensin II-AT1 and prostaglandin E2-EP1 systems (2022) (0)
Improvement in drug compliance by medical consultation at a Pharmacist Outpatients' Clinic (Part 1) (2003) (0)
Effects of lifelong intake of lemon polyphenols on aging and intestinal microbiome in the senescence-accelerated mouse prone 1 (SAMP1) (2019) (0)
NITRIC OXIDE PRODUCTION IN VIVO IN THE BRAIN FOLLOWING A DIRECT INTRAHIPPOCAMPAL INJECTION OF LIPOPOLYSACCHARIDE IN RATS (1997) (0)
[Application of a response duration schedule in rats to evaluate visual and/or auditory threshold]. (1985) (0)
Acetylsalicylic acid maltol ester attenuates methamphetamine induced neurotoxicity in mice involvement of antiperoxidative effects (2002) (0)
Involvement of glutamate receptors in the impairment of social behaviors induced by social defeat stress exposure as juveniles (2019) (0)
Allosteric changes in opioid receptors induced by the electric footshock (1985) (0)
PM376. Mountain-cultivated ginseng attenuates phencyclidine (PCP)-induced schizophrenia-like psychosis in mice (2016) (0)
Alterations of regional gamma-aminobutyric acid receptors in morphine tolerant mice. (1981) (0)
PS134. A strategy for treating in deficits of social behaviors induced by exposure to social defeat stress as juveniles (2016) (0)
The role of prostaglandin E2 in environmental factors of psychiatric disorders (2020) (0)
Adolescent mouse hippocampal function was impaired by prenatal nicotine exposure (2018) (0)
Biliary and renal excretions of cefpiramide in (1994) (0)
[JSNP Excellent Presentation Award for AsCNP 2011: enriched environment in adolescence prevents abnormal behavior associated with histone deacetylation in phencyclidine-treated mice]. (2012) (0)
P4-010 Cognitive impairment caused by neprilysin-sensitive Aβ-oligomers in mice (2006) (0)
[Pro- and anti-addictive factors related to drug addiction]. (2005) (0)
Influences of prenatal stress by the communication box on GABAergic system in the amygdala of mice. (2021) (0)
Tissue Plasminogen Activator (t-PA) Is Involved in Morphine-Induced Rewarding Effects (2004) (0)
Chronic unpredictable mild stress-induced depressive behavioral changes are associated with dopaminergic hyperfunction in the nuclues accumbens and serotonergic hypofunction in the prefrontal cortex and hippocampus of mice (2019) (0)
Combination in prenatal nicotine exposure with juvenile isolation rearing induces depressive behavior and change of tryptophan metabolism (2018) (0)
[Role of cytokines in drug dependence]. (2003) (0)
[The practice of the parenteral and enteral nutrition--from the viewpoint of the pharmacist]. (2001) (0)
[JSNP Excellent Presentation Award for AsCNP 2011: overexpressions of "shati" in the dorsal striatum or nucleus accumbens affect emotional behaviors in mice]. (2012) (0)
The mice with exonic Reln deletion show cognitive dysfunction but not attention impairment in the touchscreen operant tasks (2021) (0)
Prenatal valproic acid exposure-induces the hyper-NMDA receptor signaling in prefrontal cortex and autism spectrum disorder-like behaviors through hypo-signaling of 5-HT1A receptor in mice. (2022) (0)
Involvement of sigma receptors in effects of antidepressants on immobility in the forced swimming test. (1999) (0)
A Case Report on Effect of Asenapine Sublingual Tablets on Intractable Nausea in a Patient of Terminal Malignant Lymphoma with Diabetes Who Cannot Take Oral Medicine (2021) (0)
821 Nerve growth factor contents and glial fibrillry acidic protein immunoreactivity in mice brain after traumatic head injury (1993) (0)
Protein Kinase Cδ Gene Depletion Protects Against Methamphetamine-Induced Impairments in Recognition Memory and ERK1/2 Signaling via Upregulation of Glutathione Peroxidase-1 Gene (2017) (0)
[Pharmacological action of eptazocine (l-1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benzazonine). (III) Central action of eptazocine (author's transl)]. (1981) (0)
Beneficial treatment of nicotine in methamphetamine (METH)-induced impairment of sensorimotor gating (2009) (0)
Development of Anti-Dementia Drugs for Alzheimer’s Disease: Present And Future (2002) (0)
QPRT Deficit Leads Motor and Cognitive Dysfunction through Increase of Oxidative Stress in the Dopaminergic Neuronal System by Quinolinic Acid (2020) (0)
Morphological changes in striatum and nucleus accumbens neurons lead to abnormal behavior in ARHGAP10 mutant mice (2020) (0)
Role of Inducible Nitric Oxide Synthase in β-Amyloid-Induced Brain Dysfunction in Rats (2002) (0)
Expertise of pharmacists expected in the framework of long‐term care insurance (2015) (0)
Effects of a Rho-kinase inhibitor, fasudil on schizophrenia-like behavior and neurotransmitter release in MK-801-treated mice (2021) (0)
High salt induces cognitive impairment via the interaction of angiotensin II-AT1 and prostaglandin E2-EP1 systems. (2023) (0)
Role of IFITM3 in brain dysfunction induced by perinatal immune activation (2011) (0)
Prenatal phencyclidine-treatment inhibits neuronal production, leading to long-lasting behavioral deficits (2009) (0)
S2-4 Repeated treatment with phencyclidine induces neuropsychotoxicity : evaluation of behavioral deficits.(Proceedings of the 27th Annual Meeting) (2000) (0)
Depression-like behaviors induced by chronic social defeat stress in association with myelin abnormalities in the corpus callosum through microglial activation. (2021) (0)
Expression of Neurotrophic Factor Genes in the Hippocampus of Mice after Acute Carbon Monoxide Intoxication (ACOI) (1997) (0)
Apocynin prevents mitochondrial burdens, microglial activation, and pro-apoptosis induced by a toxic dose of methamphetamine in the striatum of mice via inhibition of p47phox activation by ERK (2016) (0)
Usefulness of Classes and Practice Session on Medicines for Children Led by Pharmacy Students (2013) (0)
Effect of microinjection of GABA into the substantia nigra zona reticulata on nigrostriatal dopaminergic neuronal activity. In vivo voltammetric study (1985) (0)
Repeated social defeat induces social interaction deficits associated with the alteration of kynurenine pathway activity in the prefrontal cortex (2018) (0)
Neuropsychopharmacological Study on an Animal Model for Negative Symptom of Schizophrenia Induced by Repeated Phencyclidine Treatment (2000) (0)
Involvement of Dysfunction of Noradrenergic Neuronal System in the Depression-Like Behaviors in MAGE-D1 KO Mice (2021) (0)
Effects of phencyclidine on gamma-aminobutyric acid receptors in the mouse (1982) (0)
DEVELOPMENT OF AMNESIA MODEL FOR SCREENING OF NOOTROPIC DRUGS AND EFFECTS OF MEVALONIC-GABA ON LEARNING AND MEMORY IN MICE (1986) (0)
Absorption of cyclosporine (Neoral) from a microemulsion formulation in a living donor liver transplant recipient. (2002) (0)
[The pharmacokinetics of oral antifungal drugs and their efficacy against cutaneous mycosis]. (2005) (0)
Up-regulation of cAMP, but not voltage-sensitive calcium ion channels is involved in the inhibitory effects of nefiracetam on methamphetamine-induced discriminative responses (2003) (0)
Neuritogenic steroid glycosides from crown-of-thorns starfish: Possible involvement of p38 mitogen-activated protein kinase and attenuation of cognitive impairment in senescence-accelerated mice (SAMP8) by peripheral administration. (2022) (0)
Antidepressant effects of XJ-Et-8 in mice chronically exposed to corticosterone (2019) (0)
β-Amyloid and neurofilaments in Alzheimer's disease and beyond (1995) (0)
Pharmacological action of phencyclidine and dopaminergic neuron in rats. (1983) (0)
Interaction between opioids and phencyclidine in relation to behavior and methionine-enkephalin contents in mice (1984) (0)
High salt intake induces hypertension and abnormal behaviors with peripheral inflammatory response (2021) (0)
Effect of Zonisamide on Plasma Concentrations of Phenobarbital. (1998) (0)
EFFECTS OF IN VIVO EXPOSURE TO HYPOXIA ON NMDA AND MUSCARINIC CHOLINERGIC RECEPTORS IN RAT HIPPOCAMPUS (1992) (0)
Japanese Abstract (2020) (0)
Pharmacological action of phencyclidine on reserpine- and p-chloroamphetamine pretreated rats (1984) (0)
Adolescent binge drinking induces behavioral abnormalities through myelin abnormalities in gray matter in adulthood (2022) (0)
Behavioral roles of Mouse Opioid Receptor-C (MOR-C), a novel opioid receptor subtype (1997) (0)
[Development of sigma-receptor ligands and clinical trials]. (1999) (0)
[Infection control in neutropenia induced by high-dose cytarabine chemotherapy]. (2004) (0)
1158 – EFFECTS OF DIFENAMIZOLE ON THE CONTENTS OF CEREBRAL CATECHOLAMINES AND THEIR METABOLITES IN MICE (1978) (0)
No relationship between dysfunction of learning and memory on the various tasks and nerve growth factor contents in the brain in senescence accelerated mice (SAM). (1994) (0)
Exposure to valproic acid during pregnancy induces autism endophenotypes in the male offspring (2018) (0)
A Permission System for Carbapenem Use Reduced the Incidence of Drug-Resistant Bacteria and Cost of Antimicrobials at A Community Hospital in Japan (2012) (0)
[Application of a shuttle avoidance schedule in rats to evaluate a drug-induced auditory impairment (author's transl)]. (1981) (0)
Inhibitor of narcotic analgesic dependence / resistance development (1996) (0)
PM487. Presynaptic protein Piccolo knockdown in the prefrontal cortex induces cognitive and emotional impairment in mice. (2016) (0)
Overexpression of astroglial major histocompatibility complex class I in the medial prefrontal cortex impairs visual discrimination learning in mice (2020) (0)
[Role of tissue plasminogen activator in the rewarding effect of morphine]. (2006) (0)
PS122. Overexpression of N-acetyltransferase Shati/Nat8l in the dorsal striatum induces depression-like behaviors in mice. (2016) (0)
Oral vaccination with a viral vector containing A (cid:1) cDNA attenuates age-related A (cid:1) accumulation and memory deﬁcits without causing inﬂammation in a mouse Alzheimer model (2007) (0)
94 Neuroprotective effects of interleukin-6 in PC12 cells (1996) (0)
Phencyclidine increases the extracellular acetylcholine level in the rat parietal cortex partly through sigma receptors (1995) (0)
PT686. Dextromethorphan-induced serotonin syndrome is via up-regulation of 5-HT1A receptors. (2016) (0)
Involvement of central serotonergic system in the thyrotropin releasing hormone-induced suppression of intracranial self-stimulation (1989) (0)
Prostaglandin E receptor subtype EP1 deficiency elicits AD/HD-like behavior correlated with a dysfunction of dopamine D1 receptor-ERK signaling in the prefrontal cortex (2018) (0)
[JSNP Excellent Presentation Award for AsCNP 2011: combination of a neonatal viral infection with an adolescent substance use affect psychological function in adult]. (2012) (0)
CBP Mutant Mice Showed A Reduced Morphine Withdrawal Syndrome And Altered Gene Expressions (1999) (0)
Neuroscience 2009 Committee (2009) (0)
Selective and competitive inhibition of kynurenine aminotransferase 2 by glycyrrhizic acid and its analogues (2019) (0)
406 Measurement of nitrite and nitrate in the cerebellum of awake rats by using in vivo brain microdialysis (1996) (0)
Effects of naftidrofuryl oxalate on 5-HT2 receptors in the mice brain using quantitative autoradiography. (1991) (0)
S1-2 BEHAVIORAL TOXICITY AND NEUROTRANSMITTERS (1990) (0)
Effects of Nicotine on Stress Response in Mice (2004) (0)
Studies on biogenic amines and behavior (III). The relationship between brain serotonin and defecation in rats. (Part 2) (1976) (0)
Serum Metabolic Profiles of the Tryptophan-Kynurenine Pathway in the high risk subjects of major depressive disorder (2020) (0)
Deficiency of kynurenine 3-monooxygenase exacerbates impairment of prepulse inhibition induced by phencyclidine. (2022) (0)
Behavioral impairment in SHATI/NAT8L knockout mice via dysfunction of myelination development (2017) (0)
The metabolic response to hydrogen chloride and acetic acid in rabbit during total parenteral nutrition (TPN) (1999) (0)
Exposure to Far Infrared Ray Protects Methamphetamine-Induced Behavioral Sensitization in Glutathione Peroxidase-1 Knockout Mice via Attenuating Mitochondrial Burdens and Dopamine D1 Receptor Activation (2018) (0)
Involvement of PGE2/EP1-tau phosphorylation signaling in the high salt intake-induced hypertension and emotional and cognitive dysfunctions (2022) (0)
Establishment of an in vivo calcium imaging method to evaluate neuronal activity in mice carrying mutations of Arhgap10 gene (2022) (0)
Copper Deficiency under Total Parenteral Nutrition at Home : Clinical Analysis of Two Cases (2006) (0)
Influence of morphine addiction on hepatic microsanal functions of mouse (1987) (0)
S5-4 Psychobehavioral deficits induced by a non-competitive N-methyl-D-aspartate receptor antagonist and signal transduction through N-methyl-D-aspartate receptors(SYMPOSIUM 5: PHYSIOLOGY AND DISEASE OF GLUTAMATE IN NEURONAL AND GLIAL CELLS)(Proceedings of the 31st Annual Meeting) (2004) (0)
NEUROTOXICITY OF CARBON MONOXIDE IN CENTRAL NERVOUS SYSTEM (1994) (0)
Genetic and animal model analyses reveal the pathogenic role of a novel deletion of RELN in schizophrenia (2018) (0)
Memory Impairment in Rats Induced by an Active Fragment of Nerve Growth Factor Antibody (1990) (0)
[Candidate genes or compounds for therapeutic tools against methamphetamine and/or morphine-induced dependence]. (2003) (0)
Participation of opiate systems in footshock-induced analgesia and motor suppression in mice (1983) (0)
Cell type-specific activation of mitogen-activated protein kinase in D1 receptor-expressing neurons of the nucleus accumbens potentiates stimulus-reward learning in mice (2018) (0)
Antibiotic releasing hydroxyapatite beads. (1995) (0)
Effects of acute and chronic morphine (M) administration on GABA binding of synaptic membrane in mice (1980) (0)
[Application of a response duration schedule in rats to evaluate drug-induced auditory impairment (author's transl)]. (1978) (0)
Effects of galantamine on social interaction impairments in cholecystokinin receptor-2 overexpression mice. (2022) (0)
Effects of difenamizole on content of catecholamines and metabolites in mouse brain. (1978) (0)
Evaluation of Inpatient Consultation Using a "Medical Diary". (1999) (0)
Emotional behavior and endocrine function in dopamine-deficient mutant mice (1998) (0)
Effect of semi-fluid diet breeding on the hippocampal dopamine release (2007) (0)
Propentofylline Prevents (2018) (0)
PKA/CREB/c-fos pathway in the hippocampus is involved in spatial memory fomation in rats (2001) (0)
Establishment of PD analysis of MMF : Comparison between MTT assay and FCM (2006) (0)
Role of Mitochondria in Methamphetamine-Induced Dopaminergic Neurotoxicity: Involvement in Oxidative Stress, Neuroinflammation, and Pro-apoptosis—A Review (2018) (0)
[Mitochondrial benzodiazepine receptors (MBR) in association with neurological disorders]. (1998) (0)
A Study on Methods for Preparing Packages Contatining Low Doses of Tacrolimus (2003) (0)
Preparation of Alzheimers Animal Model and Brain Dysfunction Induced by Continuous $\beta$-Amyloid Protein Infusion (2001) (0)
Involvement of increased kynurenic acid through downregulation of kynurenine-3-monooxygenase in depressive-like behavior and dysregulation of hypothalamic-pituitary-adrenal axis induced by chronic unpredictable mild stress (2022) (0)
Acute methamphetamine administration impairs cognitive function in a mouse model of schizophrenia with both of CNV and SNV in ARHGAP10 gene that confer high risk of schizophrenia with severe clinical symptoms. (2019) (0)
The cognitive function of the mice with an exonic deletion of RELN is impaired in touchscreen-based visual discrimination task (2020) (0)
Phencyclidine-induced Motivational Properties in Mice (1998) (0)
PT565. Prenatal nicotine exposure impairs adolescent mouse hippocampal function (2016) (0)
N-Methyl, N-propynyl-2-phenylethylamine (MPPE), a Selegiline Analog, Attenuates MPTP-induced Dopaminergic Toxicity with Guaranteed Behavioral Safety: Involvement of Inhibitions of Mitochondrial Oxidative Burdens and p53 Gene-elicited Pro-apoptotic Change (2015) (0)
Xanthoceraside attenuates amyloid β peptide25–35-induced learning and memory impairments in mice (2011) (0)
Microinjection of Reelin into the medial prefrontal cortex improves MK801-induced memory impairment (2018) (0)
Effects of imipramine on auditory sensitivity in the rat in relation to initial sensitivity (1976) (0)
Molecular mechanism of amyloid _-peptide-induced impairment of neurotransmission and memory in relation to oxidative stress (2005) (0)
Cognitive effects in animals and man (1994) (0)
Prenatal nicotine exposure induces behavioral changes of the offspring: Involvement of cytokine levels in the brain. (2019) (0)
Involvement of kynurenine pathway in behavioral impairments in the offspring induced by the prenatal poly I: C injection (2018) (0)
Title Page / Table of Contents, Supplement 2, 1994 (1994) (0)
Erratum: Chikako, S.; Yoshihisa, W.; Youichi, T.; Toshitaka, N. Influence of Housing Systems on Physical, Emotional, and Cognitive Functions with Aging in DBA/2CrSlc Mice Animals 2020, 10, 746 (2020) (0)
Prefrontal cortex, dorsomedial striatum, and dentate gyrus are necessary in the object-based attention test in mice (2020) (0)
Effects of vinconate on maze performance deficit induced by monoaminergic dysfunction in rats. (1994) (0)
Experimental research on the local delivery of adriamycin incorporated into hydroxyapatite beads. (1993) (0)
Effects of chronic infusion of beta-amyloid peptides on the nicotinic receptor binding and phorbol dibutyrate binding in rat brain (1999) (0)
Role of IFITM3 in polyI: C-induced neuronal impairments (2018) (0)
Pharmacological blockade of dopamine D1- or D2-receptor in the prefrontal cortex induces attentional impairment in the object-based attention test through different neuronal circuits in mice (2021) (0)
[JSNP Excellent Presentation Award for CINP2014]. (2015) (0)
[Regulation by tissue plasminogen activator of rewarding effects of drugs of abuse]. (2008) (0)
Usp46, encoding a ubiquitin specific peptidase, is a quantitative trait gene underlying “behavioral despair” in mice (2010) (0)
The pharmacokinetics and renal excretion mechanism of tobramycin and cefazolin in endotoxemic rats (1993) (0)
Impact of perinatal immune activation on neuropsychological development (2010) (0)
Importance of Consultation about Medicine(PUBLIC NIGHT SEMINAR : HOW THE SAFETY OF MEDICINES IS INSURED) (2002) (0)
Behavioral characterization of mice overexpressing human dysbindin-1 (2014) (0)
Effects of Diisopropylfluorophosphate (DFP) on GABAergic Function (1983) (0)
Neurochemical and psychopharmacological approaches to cognitive enhancers: Preface (1997) (0)
Analysis of motor, learning, and pituitary function in dopamine-deficient mice (1998) (0)
Nicotine attenuated chronic unpredictable mild stress-induced depressive-like behavior via elevation of serum corticosterone level (2021) (0)
[Evaluation methods for the discriminative stimulus and possible mechanisms of discriminative stimulus effects of methamphetamine in the rat]. (2005) (0)
Usefulness of Iontophoresis for Delivering Lidocaine in Local Anesthesia for Pain Related to Shunt Puncture in Patients Undergoing Dialysis (2006) (0)
Practical Clinical Pharmacy Training through Cooperation between Medical and Pharmaceutical Schools: Resident Faculty-led Practical Training Employing "Age-mixing Method" (2009) (0)
Visual searchhasnomemory (0)
Role of catecholamines and cyclic AMP systems in phencyclidine and morphine dependence. Study of mutant mice (2000) (0)
Latent copper deficiency in enteral nutrition (2003) (0)
Ovariectomy potentiates β-amyloid-induced working memory deficits in rats (1999) (0)
Effects of imipramine on open-field behavior in relation to initial level of ambulatory activity (1981) (0)
[Drug addiction research using intravenous self-administration procedure in mice]. (2010) (0)
Preferred Characters in the Directions Printed on the Medicine Bags. (1999) (0)
Npas4-Homer1a pathway regulates neuronal homeostasis in animal model of epilepsy (2018) (0)
JSNP excellent presentation award for CINP2016: A strategy for treating in deficits of social behaviors induced by exposure to social defeat stress as juveniles (2017) (0)
EVALUATION OF IL-2 MRNA IN WHOLE BLOOD AS A PARAMETER OF MONITORING CYCLOSPORINE PHARMACODYNAMICS (2004) (0)
Minae Niwa Neurons via Glucocorticoids Induced Epigenetic Control of Dopaminergic − Adolescent Stress (2013) (0)
The cerebellar α6 subunit-containing GABA A receptor: A novel therapeutic target for disrupted prepulse inhibition in neuropsychiatric disorders (2018) (0)
Our Expectation for Research Laboratories of Pharmaceutical Companies. Messages from the Persons in Charge of Clinical R&D, Medical Representatives and Hospital Pharmacists. (2000) (0)
The Present Condition of Narcotic Occupation in National University of Hospital and Its Future Problem. (1993) (0)
[Promoting Appropriate Use of Medications by "Lectures and Practices Regarding Medicine" for the Regional Community Residents]. (2023) (0)
Effects of NG-nitro-L-arginine methyl ester (L-NAME) and cytochrome P-450 inhibitors on glutamate receptor agonist-induced increase in nitric oxide metabolite levels in the rat cerebellum in vivo (1997) (0)
Influences of prenatal nicotine exposure on behavioral functions of the offspring: Involvement of chemokine levels in the brain. (2019) (0)
Documenting the value of a pharmacist-managed anticoagulation classroom (2008) (0)
The development of levofloxacin-bonded albumin Dacron graft. (1996) (0)
Shati/Nat8l deficiency impairs attention by disrupting dopaminergic projections of the ventral tegmental area-prefrontal cortex in mice (2022) (0)
Dissociable role of tumor necrosis factor alpha gene deletion in methamphetamine self-administration and cue-induced relapsing behavior in mice (2011) (0)
Current understanding of methamphetamine-associated dopaminergic neurodegeneration and psychotoxic behaviors (2017) (0)
Inhibition of Rho-kinase ameliorates decreased spine density in the medial prefrontal cortex and methamphetamine-induced cognitive dysfunction in mice carrying schizophrenia-associated mutations of the Arhgap10 gene. (2022) (0)
Enhancement ofimmobility inaforced swimming test by subacute orrepeated treatment withphencyclidine: anew modelofschizophrenia (1995) (0)
EFFECTS OF PROPENTOFYLLINE(PPF) ON BASAL FOREBRAIN LESIONINDUCED AMNESIA IN RATS (1992) (0)
Involvement of kynurenine 3-monooxygenase in the vulnerability to the PCP-induced behavioral abnormalities (2018) (0)
Association between effect of duloxetine on chronic orofacial pain and expression of platelet serotonin transporter in patients with burning mouth syndrome and atypical odontalgia (2022) (0)
Usefulness of weight-dispersing mattresses in preventing pressure sores at the sacral bone in elderly patients (1999) (0)
Release of levofloxacin from albumin bonded dacron graft and effect on graft infection (1996) (0)
[Behavioral analysis for spatial working memory in rats with a delayed spatial win-shift task in a radial arm maze]. (2007) (0)
Evaluation of the Information of Pharmaceutical Care for Inpatients" by Hospital Pharmacists when Inpatients Move to the Other Medical Facilities after Discharge (2001) (0)
Pentobarbital (p) tolerance and dependence in different strains of mice. Abstr. (1980) (0)
[Application of a shuttle avoidance response in rats to evaluate a drug-induced visual impairment]. (1985) (0)
Characterization of learning and memory deficits in the mice infected with LP-BM5 (1998) (0)
285 – POSSIBLE MECHANISM ON MORPHINE-INDUCED STRAUB TAIL REACTION IN MICE WITH SPECIAL REFERENCE TO NEUROTRANSMITTER-RELATED AGENTS (1978) (0)
[Pharmacological actions of eptazocine (l-1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1,H-4-benzazonine). 4. Antagonistic action of naloxone on eptazocine analgesia]. (1983) (0)
INHIBITORY EFFECTS OF SYNTHETIC SALMON CALCITONIN(SCT) ON EXCITATORY AMINO ACID(EAA)‐INDUCED NOCICEPTIVE RESPONSES (1992) (0)
Author response for "Lithium attenuates d‐amphetamine‐induced hyperlocomotor activity in mice via inhibition of interaction between cyclooxygenase‐2 and indoleamine‐2,3‐dioxygenase" (2019) (0)
Opioid kappa receptors correlate with the development of conditioned suppression of motility in mice. (1988) (0)
Difference in the Recognition for Medicine Use by Physicians and Chief Physicians in ICU (2003) (0)
RESEARCH PAPER Silibinin prevents amyloid b peptide-induced memory impairment and oxidative stress in mice (2009) (0)
Dose-dependent pharmacokinetics of enprofylline in rats (1991) (0)
EFFECTS OF OM‐853 (VINCONATE), A NOVEL CEREBRAL METABOLIC AMELIORATOR ON SPATIAL LEARNING DEFICITS INDUCED BY THE DYSFUNCTION OF ACETYLCHOLIN(ACh)ERGIC NEURONS (1992) (0)
A neuroactive steroid, dehydroepiandrosterone sulfate, attenuates the development of morphine dependence An association with sigma1 receptors (2001) (0)
Coadministration of Lidocaine and Recombinant Human Erythropoietin-Beta: Effect on Pain and of Erythropoietin Pharmacokinetics (2003) (0)
Disturbance of Disrupted-in-Schizophrenia-1 during neurodevelopment develops phenotypes of psychiatric disorders related to dysfunction of the dopaminergic system (2009) (0)
Pharmacokinetic and Pharmacodynamic Properties of Some Phencyclidine Analogs in Rats 1 ' 2 (2002) (0)
[Diagnoses and new therapeutic strategy focused on physiological alteration of tryptophan metabolism]. (2023) (0)
The effect of polyI:C treatment on endophenotypes in dominant-negative DISC1 transgenic mice (2009) (0)
S9-2 Anti-addictive and pro-addictive substances commonly involved in methamphetamine and morphine dependence(SYMPOSIUM 9: MOLECULAR MECHANISMS OF DRUG DEPENDENCE)(Proceedings of the 31st Annual Meeting) (2004) (0)
[Development of animal models, and drug discovery for schizophrenia based on the glutamate hypothesis]. (2010) (0)
Mice carrying a schizophrenia-associated mutation of the Arhgap10 gene are vulnerable to the effects of methamphetamine treatment on cognitive function: association with morphological abnormalities in striatal neurons (2020) (0)
The deficit of quinolinic acid phosphoribosyltransferase induces hypolocomotion and cognitive impairment through impairment of dopaminergic neuronal function (2019) (0)
Effect of Co-medications on Plasma Concentrations of Zonisamide. (1995) (0)
Pathophysiology of depression by alteration of tryptophan metabolism in glial cells (2022) (0)
The perinatal mice administered prostaglandin E 2 develop psychobehavioral and neuronal impairments in adults (2018) (0)
Evaluation of cognitive behaviors in young offspring of C57BL/6J mice after gestational nicotine exposure during different time-windows (2013) (0)
Changes in the brain Met-enkephalin, Leu-enkephalin and dynorphin concentrations in stressful situations (1990) (0)
The functional analysis of the muscarinic m2 vs. m4 receptors regulating the rat hippocampal acetylcholine release by antisense oligonucleotides (1998) (0)
Role of Pharmacists in Innovative Chemotherapy :: Contribution to Treatment of Recurrent Malignant Glioma@@@-再発悪性グリオーマ治療への貢献- (2007) (0)
Adolescent stress leads to glutamatergic disturbance through dopaminergic abnormalities in the prefrontal cortex of genetically vulnerable mice (2017) (0)
Effect of pentobarbital administration on protein synthesis in the brain (1981) (0)
Prenatal nicotine exposure decreases the release of dopamine in the medial frontal cortex and induces atomoxetine-responsive neurobehavioral deficits in mice (2017) (0)
[The role of a molecule associated with drug dependence, shati/nat8l]. (2013) (0)
P-9-19: Phencyclidine-induced schizophrenia negative symptom-like behavior in mice: Comparative study of risperidone andhaloperidol (1996) (0)
Iontophoretic application of prostagladin E1 (1996) (0)
Nicotine reverses scopolamine-induced amnesia through dopaminergic neuronal system in rats. (1993) (0)
Absence of kynurenine 3-monooxygenase reduces mortality of acute viral 3 myocarditis in mice 4 5 (2018) (0)
Loureirin C and Xanthoceraside Prevent Abnormal Behaviors Associated with Downregulation of Brain Derived Neurotrophic Factor and AKT/mTOR/CREB Signaling in the Prefrontal Cortex Induced by Chronic Corticosterone Exposure in Mice (2022) (0)
Lipopolysaccharide shock reveals the immune function of indoleamine 2,3-dioxygenase 2 through the regulation of IL-6/stat3 signalling (2018) (0)
PM314. Knockdown Piccolo suppressed Methamphetamine-induced behavioral changes and dopamine release in the nucleus accumbens of mice (2016) (0)
Innate immune activation of astrocytes impairs neurodevelopment via upregulation of follistatin-like 1 and interferon-induced transmembrane protein 3 (2018) (0)
YY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by β-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2 (2017) (0)
Pharmacist-managed clinics for patient education and counseling in Japan: current status and future perspectives (2015) (0)
22B-10-4 Analysis of morphine dependence mechanism using cyclic AMP responsive element binding protein binding protein (CBP) mutation mice. (1999) (0)
Relationship between emotionality and brain 5-hydroxytryptamine (5-HT) in rats (1977) (0)
Fstl1 mediates polyI:C-induced neuronal impairment. (2019) (0)
Medication Strategy for Malignant Glioma (2006) (0)
Neonatal immune activation exacerbates phencyclidine-induced behavioral phenotypes in adult (2010) (0)
An evaluation method for developing abuse-deterrent opioid formulations with agonist and antagonist combinations using conditioned place preference. (2023) (0)
DOPAMINERGIC INVOLVEMENT IN PHENCYCLIDINE-INDUCED STEREOTYPED BEHAVIOR (1985) (0)
Chronic social defeat stress induces depression-like behavior through the decrease of GLT-1 ubiquitination in the mouse prefrontal cortex. (2021) (0)
[Effect of naftidrofuryl oxalate (LS-121) on experimental amnesia model in rats]. (1988) (0)
[JSNP Excellent Presentation Award for AsCNP 2011: role of a novel molecule "shati" in animal model of dystonia]. (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Toshitaka Nabeshima?

Toshitaka Nabeshima is affiliated with the following schools:

Toshitaka Nabeshima's Academic­Influence.com Rankings

Toshitaka Nabeshima's Degrees

Similar Degrees You Can Earn

Why Is Toshitaka Nabeshima Influential?

Toshitaka Nabeshima's Published Works

Published Works

What Schools Are Affiliated With Toshitaka Nabeshima?

Toshitaka Nabeshima's AcademicInfluence.com Rankings